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ABSTRACT
The Effects of Bios Life and Exercise on Total Cholesterol, Serum Low Density 
Lipoprotein, and High Density Lipoprotein
by
Lori Jan Inderlied-Rucks
Lawrence A. Golding, PhJD. Examination Committee Chair, Distinguished Professor o f 
Kinesiology, University o f Nevada, Las Vegas
The present study was designed to determine the effects of Bios Life, a non­
prescription dietary fiber supplement, on serum lipoproteins and determine whether 
exercise accentuates this effect. Fifty male and female subjects (ages 30-60) participated 
in the study. Twenty-five subjects were exercising regularly in a supervised exercise 
program and the other twenty-five were sedentary. All participants where required to 
have a LDL-C o f 130 mg/dl or higher and none were on any cholesterol lowering 
medications. Blood was drawn three times at baseline, before the study started, 45 days 
into the program and at 90 days which was the end o f the study. Total cholesterol, HDL 
and LDL’s were analyzed by the Cholestech L.D.X. system. A mixed model ANOVA 
was used to analyze the data. The results indicated significant decreases in total 
cholesterol from baseline to 45 to 90 days (F = 18.29, p<0.05) with no significant 
difference between exercise and non-exercise groups (F = 0.20, p>0.05). The results also 
indicated significant decreases in LDL’s from baseline to 45 to 90 days (F =  21.60, 
p<0.05) with no significant difference between exercise and non-exercise groups (F =
iii
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1.59, p>0.05). The analysis o f the HDL’s yielded no significant difference between 
exercise and non-exercise groups (F = 1.07, p>0.05) no r was there a significant 
difference from baseline to 45 to 90 days (F = 1.67, p>0).05). These results suggest that 
whether or not one participates in an exercise program B ios Life will decrease total 
cholesterol and LDL’s equally without c hanging HDL’s , which may help reduce the risk 
o f coronary heart disease.
IV
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CHAPTER 1 
INTRODUCTION
Coronary heart disease (CHD) is the leading cause o f death in the United States. 
The American Heart Association (AHA) statistics show that in 1993 there were 489,970 
deaths from CHD. In 1998, as many as 1,500,000 Americans had a new or recurrent 
heart attack and about one third died. In 1993 artherosclerosis was the underlying cause 
of many o f  the 639,710 heart attack and stroke deaths. In the U.S. approximately 96 
million adults have total blood cholesterol levels o f over 200mg/dl and 37.8 million have 
levels greater than 240 mg/dl according to the AHA. These high levels are a major 
contributor to artherosclerosis and other types o f coronary artery disease. Due to its 
lifestyle etiology, CHD is expected to remain the leading cause o f death for future years. 
These statistics prove that CHD is a major public health problem and concern (Anderson, 
Zettwach, Feldman, Clark, Oeltgen & Bishop, 1988).
It has been well documented that both high levels o f  total serum cholesterol and 
specifically low-denshy lipoproteins (LDL-C cholesterol) are linked with coronary heart 
disease (Bridges, Anderson, Deakins, Dillon & Wood, 1992). From the epidemiological 
data from the Fram ingham  Heart Study elevated total serum cholesterol was determined 
to be a major coronary risk factor. Larosa and associates (1990) studied 2,282 men and 
2,845 women investigating CHD history and total cholesterol levels and concluded that 
there was definite evidence that high levels o f  total cholesterol were associated with a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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high incidence o f  CHD and that low levels o f  total cholesterol were associated with a low 
incidence o f CHD (Larosa, Becker & Fitzgerald, 1990).
The National Cholesterol Education Program (Expert Panel, 1993) recommends 
the following values for cholesterol in individuals to be:
Total Cholesterol < 200mg/dl
HDL > 35mg/dl
LDL < 130mg/dl
Individuals with 200-239 mg/dl are considered borderline risk and those with total 
cholesterol greater than 240 are at abnormal risk. Increasing HDL and decreasing LDL 
reduces the risk o f  CHD (Anderson, Riddell-Mason, Gustafson, Smith & Mackey, 1992). 
A lowfat diet was initially the main method o f reducing total cholesterol. New 
cholesterol lowering drugs are now commonly prescribed. Cholesterol lowering drugs 
were classified into bUe acids, sequestrates, nicotinic acids, statins, fibric acids and 
probucol (Anderson et al., 1988). The goals o f drug therapy was to lower total 
cholesterol, raise HDL’s and lower LDL’s. However, there were several major side 
effects. The side effects can range from itching o f  the skin, gastrointestinal distress, liver 
toxic effects, and muscular damage due to interaction between drugs and blood clots 
(JAMA, 1993).
Dietary therapy remains the first choice for treatment o f  high cholesterol. There 
is evidence indicating that dietary fiber has important lipid lowering effects and may 
reduce risk o f CHD (Bell, Hectom, Reynolds & Hunninghake, 1990). Increasing Dietary 
fiber intake is an important therapeutic treatment for other specific conditions besides 
CHD such as diabetes, hyperlipidemia, hyperglyceridemia, hypercholesterolemia and
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intestinal disorders (Anderson, Gilinsky, Deakins, Smith, O’Neal, Dillion & Oeltgen,
1991). Individuals consuming a diet high in fiber tend to have lower incidence o f  
myocardial infarction and sudden cardiac death (HaskeU, Spiller, Jensen, Ellis & Gates,
1992).
Dietary fiber is defined as “the endogenous components of plant materials in the 
diet that are resistant to digestion by enzymes produced by man” (Anderson, 1987).
There are two main types o f  fibers soluble and insoluble. In experimental studies, soluble 
fiber has been shown to reduce blood cholesterol levels. Soluble fiber increases the fecal 
excretion o f bUe acids, which may alter the quantity o f  cholesterol absorbed by the 
intestine. The fibers fi’om fi’esh fimits, vegetables, legumes, oat bran and barley appear to 
have the most significance for reducing cholesterol levels (Haskell et al., 1992).
Insoluble fiber, such as, wheat bran have essentially no effect on serum cholesterol levels.
The general purpose o f dietary fiber as therapy is to reduce elevated serum 
cholesterol levels. This is achieved primarily by reducing fat intake and consuming a 
healthy diet, rich in fiber. Dietary therapy in conjunction with regular exercise is 
considered an essential element in therapy o f  elevated serum cholesterol (Ready, 1996). 
Exercise has been shown to help in the promotion o f weight reduction which enhances 
LDL cholesterol lowering, reducing triglyceride, raising HDL, reduces blood pressure 
and decreasing the risk for diabetes mellitus (Grundy, 1986). Therefore, the combination 
o f regular exercise and diet rich in fiber should lower total cholesterol, increase HDL, 
decrease LDL and consequently reduce the risk o f  CHD.
The purpose o f  this study was to investigate the effects o f  Bios Life, a non­
prescription dietary fiber supplement, on Total, LDL cholesterol and determine whether
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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exercise accentuates this effect. The null hypothesis is that exercise does not accentuate 
the effect o f  Bios Life on Total Cholesterol, Low-Density Lipoproteins and High-Density 
Lipoproteins and the alternate hypothesis is that exercise accentuates the effect o f  Bios 
Life on Total Cholesterol, Low-Density Lipoproteins and High-Density Lipoproteins.
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CHAPTER!
LITERATURE REVIEW 
An adult male weighing 70kg would have approximately 140g o f  cholesterol 
present in the body with 8 g o f this in the plasma (Sabrine, 1977). The average synthesis 
of cholesterol in the body is about lOOOmg per day. The daily production is 
approximately 400mg from intestinal absorption and 600mg synthesized in the cells and 
the liver. An adult consuming a normal American diet ingests about lOOOmg per day. 
Every cell o f the body, except a mature red blood ceU, produces cholesterol (Sabrine, 
1977). The liver is a major organ in cholesterol synthesis. The liver must synthesize and 
maintain control over the enzymes that convert acetyl coenzyme A to cholesterol. More 
than ninety percent o f the cholesterol in the body is found in the cell membrane.
Chemical Nature o f  Cholesterol 
At the end o f the eighteenth century a French chemist de Fourcroy described the 
compound now known as cholesterol by isolating a crystalline substance from the 
alcohol-soluble fraction o f human gallstones (Sabrine, 1977). About the same time 
another French chemist Chevreue detected it in human and animal bile (Sabrine, 1977). 
After the turn o f  the century another French chemist Lecanu found cholesterol in the 
blood o f humans (Sabrine, 1977). De Fourcroy’s gave the name cholesterine from the 
Greek words Chole meaning bile and Steros meaning solid (Sabrine, 1977). The correct
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empirical formula (C2 7 H4 6 O) was published in 1888 by Reinitzer (Newsholme & Leech,
1983).
Cholesterol is probably the best known sterol, which is essential to the human 
body. “Cholesterol is found associated with the fets, but chemically it is not related to 
them. Cholesterol, a white waxy solid, is the principal sterol found in animal organisms” 
(Smolin & Grosvenor, 1997). Most o f the cholesterol found in the body occurs in free 
form, the unesterifred alcohol, which is precipitable by digitonin. The so-called bound 
cholesterol is found in much smaller portions; it is present as the ester o f long chain fatty 
acids. The largest amount o f  cholesterol is found in muscle, nervous and connective 
tissue. It is needed to synthesize vitamin D, cholic acid which is part o f bile, some 
hormones, and cortisol which promotes glucose synthesis in the liver (Smolin & 
Grosvenor, 1997).
Production, Absorption, Transportation and Excretion 
Cholesterol is not soluble in water therefore it can not enter the blood stream 
directly. Lipoproteins called chylomicron are formed to help cholesterol enter the blood 
stream (Williams, 1997). Chylomicrons are formed by combining triglycerides with 
cholesterol, free fatty acids, phospholipids, traces o f  fat soluble vitamins, steroid 
hormones and lipoproteins (Williams, 1997). Once chylomicrons are produced they will 
carry lipids from the intestines and deliver triglycerides to body cells. On the surface o f 
cells, lining the blood vessels is lipoprotein lipase which breaks down the triglycerides 
too fetty acids which can be either used as fiiel or resynthesized into triglycerides for 
storage. After the breakdown o f chylomicron cholesterol and protein remain and 
returned to the liver (Smolin & Grosvenor, 1997).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7
Crystalline cholesterol administered orally is absorbed in only small amounts 
unless some fatty material is also present in the intestine. This is not true with colloidal 
or amorphous cholesterol, which can be absorbed in the absence o f  dietary fat. Bile and 
pancreatic juices are said to be two agents, which aid in the absorption o f cholesterol, 
because the combination o f  cholesterol with bile acids increase the solubility of 
cholesterol in intestinal fluids. Pancreatic and intestinal enzymes hydrolyze cholesterol 
esters, which are later re-synthesized before reaching the lymph stream, the main route by 
which cholesterol is absorbed. Some cholesterol is absorbed directly into the blood 
stream; part o f the absorbed free cholesterol, but not the ester, is excreted in the bile; part 
is changed to coprosterol and eliminated later in the feces (Smolin & Grosvenor, 1997).
Lipids are produced in the liver, by breaking down excess protein, carbohydrate 
or alcohol to produce either triglycerides or cholesterol. In the liver triglycerides, 
cholesterol, fatty acids and returned chylomicron are formed into very-low-density 
lipoprotein (VLDL) (Smolin & Grosvenor, 1997). VLDL carries a large lipid content, 
but also contains about ten to fifteen percent cholesterol formed in the liver from 
endogenous fat stores (Williams, 1997). VLDL transport lipids out o f the liver and 
delivers triglycerides to body cells. They must be broken-down by the enzyme 
lipoprotein lipase so that fatty acids can be taken up by the cells (Smolin & Grosvenor, 
1997).
Triglycerides are removed from VLDL leaving a smaller intermediate density 
lipoprotein (DDL) which contains mostly cholesterol. These IDL’s are either transported 
to the liver or formed into low-density lipoproteins (LDL’s). LDL’s are lipoproteins that 
transport cholesterol to cells. For LDL’s to be taken up by the cells, apoliprotein B, must
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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bind with the LDL receptor. A LDL receptor is a protein on the surface o f all cells, 
which binds to LDL particles and allows their contents to be taken up for uses by the cell 
(Smolin & Grosvenor, 1997).
The body can not breakdown cholesterol esters, so it must be transported back to 
the liver where then it will be eliminated from the body as bile. This process is done by 
high-density lipoprotein (HDL). HDL’s are manufactured in the intestinal tract. They 
are then transported through blood to pick up cholesterol from cells so that the body can 
excrete it (Smolin & Grosvenor, 1997).
Metabolism
The synthetic process o f cholesterol takes place in the liver and may occur in 
other organs. In all tissues except in the brain, cholesterol is continually regenerated. I f  
any organ can be singled out as the single most important to metabolize cholesterol and 
some amount o f plant sterols, it is the hver. It can both synthesize and destroy 
cholesterol. The breakdown and lose o f cholesterol can occur in four ways:
1. By direct reduction to dihydrocholesterol or by passage through the 
intermediate cholesterone to dihydrocholesterol or coprosterol.
2. By loss o f cholesterol in the feces.
3. By conversion into steroid hormones.
4. By conversion to bile acids in the liver.
Cholesterol and Age
There are a number o f  variables that are important in determining or changing the 
level of blood cholesterol in the body. Throughout the day the level o f serum cholesterol 
remains for the most part constant, even though there is a  large variation in the rate that
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cholesterol enters and leaves the body (Winkel, Stratland & Bokelund, 1974). Over an 
extended period o f time the amount o f exdogensis cholesterol entering the body 
compared to cholesterol degradation will rise significantly (Hollister & Wright, 1956). 
This significant rise will eventually reach abnormal level o f  cholesterol (Hollister & 
Wright, 1956).
Females at birth have slightly higher levels o f  plasma cholesterol than males. 
During childhood, adolescence and early adulthood there is very little difference in blood 
cholesterol between men and women (Syerberg & Hjome, 1973). In later life males tend 
to have higher serum cholesterol levels due to higher concentrations o f VLDL and LDL. 
Serum cholesterol levels tend to be lower in premenstrual women. After the age o f  50 
male cholesterol levels tend to lower as females tend to raise slightly (Adlersberg, 
Schaefer, Steinberg & Wang, 1956). This rise in serum cholesterol levels in women is 
due to the fact that women going through menopause have lower levels o f estrogen. 
Estrogen is a cholesterol-lowering agent and the decrease o f estrogen during menopause 
is the cause o f rising serum cholesterol levels in women.
At birth plasma levels o f cholesterol are usually low around 80mg/dl (Darmady, 
Fosbrooke & Llyod, 1972). Glueck, Heckman, Schoenfeld, Steiner and Pearce, (1971) 
studied the umbilical cord blood cholesterol in 1800 consecutive unselected live births 
and found it to be about 80mg/100 ml. After birth cholesterol rises rapidly to around 183 
mg/100ml for the average male 20 to 29 years o f age depending mostly on diet 
(Fredrickson, Levy & Lees, 1967). Throughout life, cholesterol levels continue to rise 
slowly (Darmady, Fosbrooke & Lloyd, 1972). At about 50 years o f age serum
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10
cholesterol levels begin to plateau off. In men the level begins to drop slightly and in 
women blood cholesterol may continue to rise after 50 (Fredrick, Levy & Lees, 1967).
Adlerberg and associates (1956) studied approximately 1,200 healthy males and 
females between the age o f  2 and 77 years. Their blood serum was analyzed fijr 
cholesterol in order to establish average lipid levels. It was found that in the age groups 
3-12 and 53-57, the females have significantly higher cholesterol levels than men, 
whereas, in age groups 28-42 males have significantly higher levels than women. 
Adlersberg also compared the serum cholesterol levels between males and females at 
different age groups. The total serum cholesterol level of the males remained constant 
fi-om age 2 throughout 19. From the age 20 to 33 there was a significant increase o f  total 
cholesterol level. No change was seen imtil after age 60. The total serum cholesterol 
level o f the females did not change significantly from age 2 through 32. From age 33 to 
58 a  significant increase o f 3.2 mg per lOOcc per year was seen. The difference in the 
serum cholesterol levels at the different age-trends between males and females may be 
the result from evidence showing that males at a young age start to show signs o f 
coronary artery disease and among women they tend to show signs o f coronary artery 
disease after the age o f 50 around the time o f  menopause (Adlersberg, Schaefer,
Steinberg & Wang, 1956).
Diurnal and Seasonal Variations 
Several studies have examined seasonal fluctuations o f serum cholesterol in man. 
Fyfe, Dunnigan, Hamilton and Rae (1968) studied the seasonal variation o f 5,630 serum 
cholesterol and serum triglyceride on patients with confirmed or suspected ischemic heart 
disease. Serum cholesterol levels were at their peak in the spring, and fell progressively
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to the lowest level in autumn. Serum Triglyceride did not exhibit this kind o f  seasonal 
fluctuation. This study concluded that the highest level o f serum cholesterol occur in the 
spring and the lowest in the autumn (Fyfe et al., 1968).
Cholesterol and Heart Disease
Atherosclerosis is the major disease affecting the heart and blood vessels, and is 
the leading cause o f  death in the United States (Bierman & Chait, 1988). According to 
the International Atherosclerosis Project; observations were made on 19 different 
countries and race groups concluding that “practically aU persons have some degree o f 
atherosclerosis when examined at autopsy” (McHill, 1968). Atherosclerosis is a 
progressive disease throughout life. The severity which it develops seems to be due 
primarily to environmental conditions (Gresham, 1972). Since the 1960’s the number o f 
deaths from coronary artery disease has been declining at a fast rate but stül nearly half o f  
the deaths in this country are from blood vessel diseases (Lipid Research Clinics 
Program, 1984).
Atherosclerosis is the result o f  fatty cholesterol deposits in blood vessel walls; 
reducing elasticity and eventually blocking blood flow (Smolin & Grosvenor, 1997). It is 
a disorder o f the coronary arteries, cerebral arteries, iliac and femoral arteries and aorta 
that is responsible for coronary heart disease, stroke and peripheral arterial disease 
(Bierman & Chait, 1988). Atherosclerosis is characterized by the collection o f  lipids in 
smooth muscle cells, macrophages o f  the inner lining o f  the walls o f  arteries (Bierman & 
Chait, 1988).
In 1833 Lobstein introduced the word atherosclerosis, athero meaning gruel or 
musk and scleroses meaning hardening o f the arteries (Katz & Stamler, 1953). Michael
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Brown and Joseph Goldstein showed the connection between the discovery o f LDL 
receptors on cells with the development o f  atherosclerosis (Smolin & Grosvenor, 1997). 
LDL receptors bind to LDL particles and help them to be absorbed by the cell. A high 
level o f  LDL means there is too much cholesterol or not enough LDL receptors cells, this 
leads to cholesterol deposits in the artery walls causing atherosclerosis (Smolin & 
Grosvenor, 1997).
Even though extensive studies have been done on atherosclerosis, there is stdl no 
known cause o f the exact events which initiate the buildup of cholesterol in arterial walls 
(Grundy, 1990). One theory is an injury to the arterial wall is caused by high blood 
pressure, viruses, chemicals or some other factor (Brown & Goldstein, 1984). Another 
theory suggests that the presence of high levels o f  blood cholesterol causes injury to the 
arterial wall (Brown & Goldstein, 1984). Inside the artery wall, as the injury occurs, 
oxidized LDL cholesterol binds to scavenger receptors located on the surface o f  the white 
blood cells. The white blood cells fill up with the oxidized LDL cholesterol and burst 
depositing cholesterol to form a fatty streak inside the artery wall. This process leads to 
an excessive amount o f cholesterol, smooth muscle cells and fibrous tissue called plaque. 
The plaque will collect calcium causing it to became hard. Blood clots wUl form around 
the plaque causing the artery to narrow and lose it’s elasticity. The artery becomes 
blocked and will no longer allow blood flow to supply oxygen and nutrients to the ceU, 
leading to the death o f cells (Smolin & Grosvenor, 1997).
Atherosclerotic lesions in the coronary arteries lead to CHD, which is the most 
common and most serious o f cardiovascular diseases in middle-aged adults (National 
Research Coimcil, 1989). If  atherosclerosis causes interference with blood flow to the
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myocardium a Myocardial Infarction results. One third o f aU myocardial infarction 
cases, coronary artery occlusion is the cause o f death in myocardial cells (National 
Research Council, 1989). Patients may also suffer from failure o f the heart to pump 
sufficient blood, known as congestive heart failure, or irregular heart beats, known as 
arrhythmias. The presence o f severe lesions in the coronary arteries will often cause 
angina pectoris, especially on exertion (National Research Council, 1989).
Cholesterol has received much attention, especially in view o f the well known 
clinical fact that certain diseases and syndromes often associated with 
hypercholesteremia, including diabetes mellitus, the nephrotic syndrome, myxedema, and 
familial hypercholesteremia, predispose to premature atherosclerosis. In spite o f the fact 
that cholesterol levels are often above 260 mg in persons with atherosclerosis, there is 
evidence that a high proportion o f people develop atherosclerosis with blood levels in the 
normal range o f  125 to 260 mg (Barry, 1997).
Incidence o f CHD varies widely from one country to another, which sparked the 
interest o f researchers to answer the question o f why cholesterol in blood and coronary 
heart disease is so different between countries (Frayn, 1996). Researchers started by 
looking at international coronary artery disease mortality data and autopsy records from 
cross-population studies which provided evidence supporting a significant association 
between CAD and dietary fat intake (Caggiula & Mustad, 1997). The Seven-Country 
study and the Japan-Honolulu-San Francisco study established the importance o f the fatty 
acid composition o f  dietary fats with the link o f increased rates o f CHD.
In the “Seven Country Study” dietary intake o f the participants was done by a 7- 
day food record and then a sample o f  each food consumed was chemically analyzed. The
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results showed in Finland and the United States total fat intake was 40% o f energy and in 
Japan it was 20% o f  energy. Saturated Fatty Acid (SFA) intake ranged from 20% in the 
United States to less than 10% o f  energy in Japan. This study was the first to show a 
strong correlation between SFA, coronary artery disease and death. This study showed 
that coronary artery disease rates were low despite moderately high total fat intakes, 
especially when SFA intakes were high (Keys, 1970).
Three middle-aged men o f  Japanese ancestry living in either Japan, Honolulu or 
San Francisco participated in a study observing the relation between SFA, cholesterol and 
heart disease. The intake o f total fat differed significantly among the three different 
cultures. In Japan the percent o f energy from fat was 15%, in Honolulu it was 33% and 
San Francisco participants SFA intake ranged from 7%, 13% and 38% (Kato, Tilloston, 
Nichaman, Rhodes & Hamilton, 1973). Coronary artery disease mortality was 1.7 times 
higher in Hawaii and 2.8 times higher in San Francisco than in Japan. Although no single 
dietary factor existed that is associated with coronary artery disease between and within 
aU different countries the mortality in these populations SFA and cholesterol are 
generally positively correlated with coronary artery disease (Kato et. al., 1973).
There are specific differences in death rates from coronary artery disease among 
most industrialized countries (Shils & Young, 1988). The highest rate o f CAD in males 
between 35 and 74 years is seen in Finland and the United States. Eastern Europe and 
Japan are about one fifth o f that in the United States. These differences in CAD maybe 
due to genetic factors, but as seen with Japanese migrants to the United States they have 
rapidly accumulated the risk o f artherosclerosis through western diet and lack o f exercise 
(Shils & Young, 1988). Evidence suggests that cultural and environmental factors
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including diet may have an important part in CAD, but genetics probably explains the 
difference in CAD among individuals from the same ethnic and cultural background 
(Shils & Young, 1988).
There are a number o f conditions and habits that are correlated with the incidence 
o f CAD and these have been termed “coronary risk factors” (Dawber, 1975). Non- 
reversible risk factors or otherwise known as primary risk factors are aging, male sex and 
genetic traits: i.e. positive family history o f  premature atherosclerosis (Dawber, 1975). 
Potentially reversible risk factors or Secondary risk factors are: cigarette smoking, 
hypertension, obesity, hyperlipidemia, hypercholesterolemia, hyperglycemia, diabetes 
mellitus, low levels o f  HDL’s and sedentary lifestyle (JAMA, 1993). Other possible risk 
factors are body build, emotional stress and personality type (JAMA, 1993).
Hyperlipidemia consists o f increased plasma levels o f  cholesterol and/or 
triglycerides (Dawber, 1975). The elevated plasma hpid levels result from one or more 
abnormalities o f  lipid metabolism or transport (Dawber, 1975). Hypercholesterolemia 
and hypertriglyceridemia seem to play an important role in the development of 
atherosclerosis.
Hypercholesterolemia is associated with increased incidence o f  premature CAD, 
but it’s importance varies in relation to age. The incidence o f myocardial infarction in 
individuals between the ages o f  30 and 49 with cholesterol levels greater than 260 mg/dl 
was three to five times higher than in individuals with cholesterol levels less than 2 0 0  
mg/dl (Bierman & Ross, 1977).
Hypertriglyceridemia has a significant relationship to CAD due to increased 
triglycerides and very low density lipoproteins (VLDL) (Assmann & Schulte, 1992).
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Individuals with elevated VLDL levels may have an increased risk for premature 
atherosclerosis due to the fact that high levels o f VLDL will be transformed into LDL 
and an even higher risk if  the individual has other risk fectors such as diabetes, smoking 
and hypotensive (Assmann & Schulte, 1992).
Goldstein (1973) studied the role o f genetics o f  hyperlipidemia in atherosclerosis 
in 500 survivors o f  myocardial infarctions. The study showed that approximately one 
half o f  the males and two thirds o f  females below the age o f 50 had either 
hypertriglycerdemia, hypercholesterolemia or both. In the individuals over 70 the 
presence o f atherosclerotic coronary disease was high, but no males and one fourth o f  the 
females had hypertriglycerdemia or hypercholesterolemia. It appears that hyperlipidemia 
is more of a risk factor in individuals below the age o f  50, and for men and women over 
the age of 65, however, there is no evidence to support a  correlation between 
hyperlipidemia and atherosclerosis (Goldstein, Hazzard, Schrott, Bierman & Motulsky, 
1973).
Cholesterol and Fiber 
Treatment o f high total blood cholesterol begins with dietary therapy. The goal of 
dietary therapy is to lower LDL-cholesterol to levels under 130 mg/dl if definite CHD or 
two other CHD risk factors are present (Expert Panel, 1993). The general purpose o f 
dietary therapy is to reduce elevated cholesterol levels while maintaining a healthy 
adequate diet. Modification o f the patient’s diet is an essential element of therapy 
(Expert Panel, 1993). One o f  the important modifications to help reduce high levels o f 
cholesterol through diet is to increase the intake o f dietary fiber (Anderson et al., 1991).
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The effect o f  fiber in various disease conditions has been studied for several 
years. British scientists in the 1960’s concluded that many diseases and disorders o f  the 
Western society were related to a low intake o f  dietary fiber (Council on Scientific 
Affairs, 1989). They compared Western cultures to  rural Afirican blacks and found that 
cancer o f the colon and gastrointestinal disorders were rare in this society due to high- 
fiber diets and production o f soft stools in large volume (Council Scientific Affairs,
1989). In Western cultures where life-styles and diet contain high amounts o f  saturated 
fat and low amounts o f fiber the incidence o f heart disease is much higher (Council 
Scientific Affairs, 1989).
Dietary fiber has been shown to have an important lipid lowering effects and may 
reduce risk for coronary artery disease (Anderson & Tietyen-Clark, 1986). Dietary 
fibers, are the endogenous components o f  plant material in the diet that are resistant to 
digestion by enzymes produced by man (Pilch, 1987). Dietary fibers can be classified 
according to their water solubility. Most water insoluble fibers such as cellulose, 
cellulose-rich products and lignin (i.e. wheat bran) do not lower serum cholesterol 
concentrations o f  humans or animals (Anderson, 1987). Water-soluble fibers (pectins, 
gums, and mucilages) and diets high in water-soluble fiber fi'om oats and bran decrease 
the glycémie response to foods and lower serum cholesterol concentrations (Anderson, 
1987).
The theories o f  how fiber lowers cholesterol levels include the following: (1) 
Soluble fibers bind bile acids and other lipids and may interfere with micelle fijnnation in 
the small intestine resulting in alterations in the quantity o f  cholesterol or fetty acids 
absorbed or altering the size o f  lipoprotein particles formed by intestinal mucosa (Council
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on Scientific AflFairs, 1989). (2) Soluble fibers increase the fecal excretion o f bile acids 
and may interfere with cholesterol and bile acid homeostasis sufiiciently to affect hepatic 
secretion o f  lipoproteins. (3) Soluble fibers fermented by colonic bacteria form gases and 
short chain fatty acids (Council on Scientific Affairs, 1989). Short Chain fatty acids are 
almost completely absorbed into the portal vein and could effect hepatic cholesterol 
synthesis (Council on Scientific Affairs, 1989). However various types o f  dietary fiber 
have different effects on serum cholesterol (Anderson & Chen, 1979). Soluble fiber 
(Pectin, guar gum, barley and oat bran) have been shown to reduce blood cholesterol 
levels, when given in large amounts (Life Sciences Research OfiBce, 1987). The fibers 
fi-om fi-esh fimits, vegetables, legumes, oat bran and barley appears to have the most 
potential for reducing cholesterol levels (Life Sciences Research Office, 1987). Insoluble 
fibers such as wheat bran have a very small or no effect on serum cholesterol levels 
(Nutrition Committee, American Heart Association, 1988).
Anderson and associates (1991) studied 20 hypercholesterolemic men admitted to 
a hospital metabolic ward. They were randomly divided into either an oat bran or wheat 
bran group for 21 days after a 7-day control-diet period. Both the control and treatment 
diets were designed to have the same energy content and nutrients, the only difference is 
in the amounts o f soluble fiber. After the 21 day o f treatment oat bran significantly 
decreased total cholesterol by 12.8% and lov/ density-lipoprotein cholesterol by 12.1%. 
Wheat bran had no significantly change. In both groups high density lipoprotein did not 
change significantly. They concluded that oat bran could have been effective in 
reducing the risk for CHD, since they found a significant reduction in total cholesterol 
and low density lipoproteins (Anderson et al., 1991).
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Kestin, Moss, Clifton and Nestel (1990) had similar findings on 24 mildly 
hypercholesterolemic men on the effects o f adding 11.8g dietary fiber per day from each 
o f  three cereal brans (wheat, rice and oat) to a low-fiber diet for 4 weeks each. The 
subjects were placed on a low-fiber diet for 3 weeks and randomly allocated to consume 
the wheat, rice, or oat-bran supplement for 4 weeks in a double-blind crossover design. 
Altogether there were six orders o f  treatment and the study lasted 90 days. At the end o f 
each period a fasted blood draw was done. Plasma total and low-density lipoprotein 
cholesterol concentrations were significantly lowered by oat bran. Oat bran significantly 
lowered the plasma total cholesterol concentration by 5.6%. This decrease was seen 
mainly in the LDL-cholesterol Auction. In both the rice and oat bran a slight increase 
was seen in the HDL cholesterol concentration o f 2.9% in rice bran and 4.0% in the oat 
bran when compared with the wheat bran. They concluded that an increase intake of 
fiber-rich foods from several sources might help prevent coronary heart disease and 
cancer. However, the consumption o f a single food source o f fiber such as oat bran or rice 
bran is unlikely to help lower plasma lipoprotein concentrations (Kestin, Moss, Clifton & 
Nestel, 1990).
Oat-bran is a palatable cereal which is rich in water-soluble fiber (Kestin, Moss, 
Clifton & Nestel, 1990). Oat products, have important hypocholesterolemic properties as 
demonstrated in both humans and animals (Judd & Truswell, 1988). A 6 week study 
looking at oat-bran supplementation o f 50g per day in the diets o f 12 healthy young 
people showed a decrease o f serum cholesterol by 12% (Storch, Anderson & Young,
1984). In studies using larger intakes o f oat bran serum total cholesterol lowered by 13-
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19% and LDL cholesterol lowered by 14-23% with no change seen in HDL cholesterol 
(Anderson, Story, Sieling, Chen, Petro & Story, 1984).
Anderson et al. (1990) studied 12 men with high serum total cholesterol 
concentrations to determine the effects o f a ready-to-eat oat bran cereal on lipid 
concentrations. Subjects were randomly assigned to either 56g o f oat bran cereal or com 
flakes. Both diets were 43% o f energy from carbohydrate, 41% fat, 16% protein. After 
completing the first diet, subjects completed 2 weeks on the alternate diet. The oat bran 
cereal diet compared with the com flakes diet lowered semm total cholesterol by 5.4%. 
LDL cholesterol decreased by 8.5% and HDL cholesterol decreased by 3.3% on the oat 
bran diet (Anderson, Spencer, Hamilton, Smith, Tietyen, Bryant & Oeltgen, 1990).
Kirby, Anderson, Sieling, Rees, Chen, Miller and Kay (1981) had similar findings 
on eight men who were fed control and oat bran diets with previously documented 
hypercholesterolemia. The men were fed two identical solid diets that only differed in 
the inclusion o f 1 OOg o f oat bran per day provided in muffins and hot cereals. Each 1 OOg 
o f the oat-bran preparation contained 26.4g o f plant fiber including 14.8g o f water- 
soluble fiber. The diets were randomized alternating each group to the other diet after 10 
days. Serum concentrations o f total cholesterol, triglycerides and glucose were measured 
daily after a 10 hour fast. They measured plasma HDL cholesterol concentrations on 2 or 
3 days at the end o f each dietary period and calculated values for LDL cholesterol. 
Patients tolerated both diets well and ate 94% o f the oat bran served. The non-bran 
control diets had a 5% increase on serum total cholesterol concentrations and in the oat 
bran group an 18% decrease in serum cholesterol concentrations. The decrease in total 
semm cholesterol was from a 14% reduction in LDL cholesterol whereas the cholesterol
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concentrations did not change. Concluding that palatable and inexpensive high fiber 
foods such as oat bran may have an important role in treating hypercholesterolemia.
Anderson et al. (1984) examined 20 hypercholesterolemic men who were 
randomly allocated to oat-bran or bean supplemented diets for 21 days in a hospital 
metabolic ward. They developed control and experimental diets that were virtually 
identical in nutrient content and differed only in the amount o f plant fiber. The oat-bran 
diet provided lOOg o f  oat bran per day served as hot cereal and five oat-bran muffins a 
day. Oat-bran diet supplied approximately 47g total plant fiber and 17g soluble fiber per 
day. The bean diet contained 115g o f  dried bean per day, which provided approximately 
the same amount o f  total plant fiber and soluble fiber as did the oat-bran diet. After the 
21 days a 10 hour fasting blood draw was taken to measure serum cholesterol, 
triglyceride and HDL cholesterol. The subjects ate 98% of the oat bran provided and an 
average o f 88% o f the beans served. Subjects consumed the oat-bran without difficulty. 
The subjects who consumed the beans complained o f mild abdominal distension and gas 
production. Oat-bran diets decreased serum cholesterol concentrations by 19% and low- 
density hpoprotein cholesterol by 23%. Bean diets decreased serum cholesterol 
concentrations by 19% and low-density lipoprotein cholesterol by 24%. Oat-bran 
supplements and bean supplements had almost identical effects on serum total cholesterol 
by reductions o f approximately 19% and LDL cholesterol concentrations by about 24%. 
Neither diet was accompanied by substantial reductions in HDL cholesterol 
concentrations. They concluded that oat-bran or bean supplement might have substantial 
therapeutic benefits in the long-term management o f selected patients with 
hypercholesterolemia.
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These studies document the hypocholesterolemic effect o f  soluble-fiber rich foods 
(Anderson & Chen, 1979). The lipid lowering effects o f soluble-ffbers such as guar gum, 
locust bean gum, pectin, oat bran, legumes and psyllium have all shown significant 
cholesterol lowering effects (Anderson et al., 1992). Considering the side effects of 
many cholesterol lowering drugs adding soluble fiber to the diet has been suggested as a 
safe, practical and cost effective alternative to help reduce serum cholesterol 
concentrations and may have a substantial impact in lowering the risk for CHD (Kinosian 
& Eisenberg, 1988; Witztum 1989, Anderson, Deakins, Floore, Smith & Whitis, 1990).
Cholesterol and Exercise 
Individuals who engage regularly in cardio-respiratory activities are leaner and 
more physically fh in general than sedentary individuals. They also are reported to have 
higher plasma concentrations of high-density lipoprotein cholesterol (HDL-C) and lower 
concentrations o f total cholesterol, low-density lipoprotein cholesterol (LDL-C), very- 
low-density lipoprotein cholesterol (VLDL-C), and triglycerides than sedentary control 
subjects (Williams, Wood, Haskell & Vranizan, 1982). It is still uncertain whether 
physical activity can favorably influence the process o f coronary artery disease and 
coronary heart disease in human beings (Kramsch, Aspen, Abramowitz, Kreimendahl & 
Hood, 1981). Recent studies appear to support the belief that regular aerobic exercise 
may protect against premature cardiovascular disease (Kramsch et al., 1981). 
Observations firom early investigations indicated lower triglyceride concentration in 
endurance-trained subjects while total cholesterol was either not changed or only slightly 
different. However, it became evident that physical activity had an impact on the 
lipoprotein lipid distribution, and later investigations have focused on the measurement o f
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both the cholesterol and protein content associated with these various lipoproteins 
(Kendler, 1997). In most cases, regular participation in physical activity is associated 
with lower plasma triglyceride concentrations. Generally, when a  person’s base line 
plasma triglyceride concentration is elevated endurance exercise training  usually can 
reduce the high concentration (Thompson, CuUianane, Sady, Glynn, Chenevert & 
Herbert, 1991). The amount o f  the concentration that is reduced is related to the pre­
training concentration and the volume o f  exercise completed during the training  program 
(Guntelberg, Brennan, Holloszy, Schonfeld, Rennie & Weidman, 1977). Researchers 
believe that reduction in triglyceride concentrations result from both regular exercise and 
diet. Even though changing ones dietary intake can help with lowering triglyceride 
concentrations alone. It does not seem to be the absolute reason seen in people who are 
physically active (Kiens, Gad, Lithell & Vessby, 1981). This is portrayed especially in 
endurance athletes, extreme leanness is related to lower triglyceride concentrations 
(Hagan & Gettman, 1983).
Holloszy, Skinner, Toro and Cureton, (1964) studied the effects o f  a six month 
program o f endurance exercise on serum lipids o f middle-aged men. Two groups o f 
subjects were involved in this study. In group A. 15 men who all led sedentary lives for 
three or more years before the study participated in an organized exercise program 
consisting of pushups, sit-ups and distance running (2 to 4 miles) on an average o f 3.35 
times per week for six months. In group B. 12 subjects did not exercise together with an 
instructor, but participated in a program o f  distance running geared to their individual 
capacities and increasing progressively in intensity. Three festing blood sangles were 
taken on each subject over a seven day period to establish base line values. Total serum
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cholesterol levels were determined once a month, and phospholipids along with 
triglycerides measured every other month. AU three samples were taken over a seven day 
period after the study. The results o f  the serum triglycerides fell from a mean pre­
training o f208 ± 127 to 125 ±  78 mg. in both groups. The mean serum cholesterol and 
phospholipid levels did not change significantly with training. This reduction in serum 
triglycerides appears to occur within two to three hours after exercise and lasts for 
approximately two days. From their results they concluded that it would appear that 
serum triglyceride levels can be kept significantly lower by means o f  regularly performed 
endurance exercise. This finding may represent one mechanism by which exercise 
possibly could protect against coronary heart disease. (HoUoszy, Skinner, Gelson & 
Cureton, 1964).
Cholesterol is an important part o f ceU membrane and synthesis o f  steroid 
hormones however; excess (high levels oQ cholesterol is also associated with 
development o f coronary artery disease. Studies have concluded differently on whether or 
not plasma cholesterol concentrations are lower in endurance-trained male and female 
athletes when compared to inactive control groups (Williams, Krauss, Wood, Lindgren, 
Giotas & Vraganizan, 1986).
Factors such as body weight, percentage o f  body fat and differences in fe»od intake 
are important considerations when evaluating the effects o f physical activity on plasma 
cholesterol concentration. Factors such as age and gender can play an important role in 
the difference o f plasma concentrations, which can effect whether or not physicaUy active 
individuals have lower plasma concentrations than do inactive individuals (Seals, 
Hagberg, Hurley, Ehsani & Holloszy, 1984).
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Studies comparing LDL-C concentrations in men and women athletes from 
various sports with those o f  inactive subjects have produced mixed results (Thompson, 
Callinane, Sady, Flynn & Bernier, 1988). Tsopanakis, Kotsarellis and Tsopanakis (1986) 
found that athletes participating in power or speed-related events have LDL-C either 
similar or lower than those o f  inactive controls. Stein, Michielli, Glantz, Sardy, Cohen, 
Goldberg and Brown (1989) found similar findings as Tsopanakis when studying the 
effects o f different exercise training intensities on lipoprotein cholesterol fractions in 
healthy middled-aged men. They reported that LDL-C concentrations are lower for men 
and women following endurance training. However, in one study conducted by Marti, 
Suter, Riesen, Tschopp, Wanner and Gutzwiller (1990) that looked at only men and 
another study conducted by Nikkila, Kuusi and Myllyen (1980) looked at both men and 
women long distance runners reported lower LDL-triglyceride concentrations in men but 
not in women when compared with inactive controls. However, a study conducted by 
Kuusela, Vautilainen, Kukkonen and Raurammaa (1980) compared Scandinavian 
lumberjacks with sedentary workers and concluded that lumberjacks have higher LDL- 
triglyceride concentration.
Endurance-exercise training has been associated with increased HDL-C 
concentration, associating it with reduced CAD risk. There is a consensus, among cross- 
sectional studies that HDL-C concentrations are elevated typically 20-30% in endurance 
trained athletes when compared to inactive groups (Thompson, Lazarus, CuUianane, 
Henderson & Musliner, 1983). Some researchers have suggested a dose-response 
relationship between the amount o f  exercise performed and how much HLD-C will 
increase (Rotkis, Cote, Coyle & Wilmore, 1982). Some researchers do not believe that
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one bout o f  exercise can have an effect on HDL-C increasing. Reasons for the 
discrepancy may be related to several factors: the length o f  the training period, the 
volume o f  training period, the volume o f training completed, changes in body 
composition, dietary intake, weight loss, and the pre-training HDL-C concentrations 
(Weltman, Matter & Stanford, 1980).
Brownell, Bachorik and Ayerle (1982) studied the effect o f  a 10 week exercise 
program on changes in plasma lipid and lipoprotein levels in 37 women and 24 men. 
Thirty-minute sessions were held three times weekly for 3 different groups of 15-25 
subjects. The class was conducted by certified fitness instructors and focused on 
cardiopulmonary conditioning, flexibility, muscular strength and endurance. By the 
fourth week, the subjects were exercising at approximately 70% o f maximal heart rate for 
15-20 minutes. The remaining time was used for warm-up, cool-down and stretching. 
Blood samples were obtained before and after the 10-week program. Results fi'om this 
study demonstrate that men and women differ in their lipid and lipoprotein responses to 
an exercise program Men showed significant reductions o f 4.4% in cholesterol 6% in 
LDL cholesterol and 9.5% in triglycerides and a 5.1% increase in HDL cholesterol. 
Women showed a 4.1% decrease in cholesterol with no significant changes in HDL 
cholesterol or LDL cholesterol and a 14.5% decrease in triglycerides. The results fi'om 
the study concluded that moderate exercise might have different effects on men and 
women (Thompson, Lararus, Cyllianane, Henderson & Musliner, 1983).
Studies on exercise and lipid changes have proposed conflicting results between 
men and women. Studies o f men have shown consistent increases in HDL cholesterol 
during programs o f  moderate or intensive exercise and have shown either a decrease or
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no significant change in triglyceride. The HDL/LDL ratio, an important predictor o f 
coronary heart disease, increased significantly in men, but did not change significantly in 
women when participating in an exercise program. Conclusions o f this matter suggests 
that a short-term exercise program in a work setting can improve plasma lipid and 
lipoprotein patterns more in men than in women (Brownell et al., 1982).
In women, some studies showed no change in HDL cholesterol and a decrease in 
LDL cholesterol after moderate exercise (Lee, Nieman, Raval, Blankenship & Lee,
1991). In addition, it is becoming increasingly apparent fi'om studies that the quantity 
and intensity o f physical activity required to have a positive change in lipoprotein levels 
may be varied (Leon, Connet, Jacobs & Rauramaa, 1987). For instance, it has been 
shown recently that more moderate levels o f  activity can improve the lipoprotein profile 
by increasing HDL cholesterol levels and lowering LDL cholesterol levels (Duncan, 
Gordon & Scott, 1991). Researchers thought one would need to endurance train to show 
significant changes in cholesterol levels.
King, Haskell, Young, Oka and Stefanick (1995) studied 149 men and 120 
postmenopausal women to determine the two-year effects o f  differing intensities and 
formats of endurance exercise on exercise participation rates, fitness, and plasma HDL 
cholesterol levels among healthy older adults. The subjects were randomly assigned to 
one o f four groups. (1) higher-intensity group-based exercise training (2) higher- 
intensity, home-based exercise training (3) lower-intensity home-based exercise training 
(4) a 1-year delayed treatment control condition that received an exercise training 
program during the second year. The primary purpose o f the second study year was to 
evaluate the maintenance o f  changes that had occurred during the first year in the three
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experimental conditions. It also allowed the researchers to look at long-term effects of 
the three different exercise-training conditions on variables such as lipoprotein levels that 
had not changed significantly during the first year. For the higher-intensity exercise 
training, three 40-minute endurance training sessions per week were prescribed at 73% to 
88% o f peak treadmill max heart rate. For lower-intensity exercise, five 30-minute 
endurance training sessions per week were prescribed at 60% to 73%. Subjects assigned 
to the year delayed treatment control condition were requested not to change their activity 
habits during the initial 12-month study period. Changes in total cholesterol, HDL, LDL 
cholesterol and plasma triglycerides did not differ significantly between the three 
exercise training conditions versus the one-year wait-listed control group at the end o f 1 
year. By the end o f  the second year subjects in the two home-based training conditions 
showed small but significant HDL cholesterol increase fi'om baseline. The increases 
were the greatest for subjects in the lower-intensity condition, whose exercise 
prescription required more frequent exercise sessions per week. In all exercise 
conditions, increases in HDL cholesterol were associated with decreases in waist-to-hip 
ratio in both men and women. Concluding that frequency and length o f  time needed to 
achieve HDL cholesterol change may be longer for older populations (King, Haskell, 
Young, Oka & Stefanick, 1995).
Stein et al. (1989) studied the effects of different exercise intensities on 
lipoprotein cholesterol fiuctions in healthy middle-aged men. Forty-nine healthy men 
were randomly divided into four different groups o f  exercise training. The subjects 
trained at either 65%, 75% or 85% o f  their measured maximal heart rate. The fourth 
group was a 12 week non exercise control group. Fasting morning blood samples were
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obtained from all subjects before and immediately after the exercise training or control 
period. Results o f the lipid profiles showed that total cholesterol did not change 
significantly in any o f  the groups HDL cholesterol increased significantly in the 75% and 
85% maximal heart rate training groups, but not in the other two groups. LDL 
cholesterol decreased significantly only in the 75% group. No significant differences 
were seen with in any o f the groups for VLDL cholesterol or triglyceride levels. 
Concluding that an aerobic exercise at 75% maximal heart rate, 30 minutes per session, 3 
days a week for 12 weeks results in a 19% increase in HDL cholesterol and an 22% 
decrease in LDL cholesterol (Stein et al., 1989).
Elevated levels o f  plasma high-density-lipoprotein (HDL) may be associated with 
a lowered risk o f coronary heart disease (Gordon, Castelli, Hjortland, Kannel & Dawber, 
1977). Several studies have indicated that vigorous exercise training may result in 
elevated HDL cholesterol levels in young and middle aged men (Lopez, Vial, Balart & 
Arroyave, 1974). The concept o f elevated HDL levels resulting from exercise has been 
combined with the idea o f the effect which dietary modification may have on HDL levels 
(Sacks, Castelli, Donner & Kass, 1975). Some researchers have suggested that moderate 
alcohol intake and a reduction caloric intake will increase HDL levels. Hartung, Foreyt, 
Mithcell, Vlasek and Gotto (1980) studied 59 healthy middle aged marathon runners, 85 
joggers and 74 inactive men and observed the relation between diet and plasma lipids and 
lipoprotein levels in all o f  these men. The inactive subjects were men selected randomly 
from the general population who indicated that they did not exercise regularly. They 
participated in a diet-education study and were randomized into a control group. The 
marathon runners had aU completed a 26.2 mile marathon during the 12 months before
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the study and continued to train heavily. They reported an average o f  40 miles per week. 
The joggers ran at least 2 miles three times per week. Blood was drawn in the morning 
after a 12 to 16 hour fast. Height, weight, tricep skinfold and blood pressure were also 
measured and a comprehensive questionnaire was completed during the visit on the fi>od- 
intake-record section the subject was asked how many servings o f each food he ate daily 
weekly, monthly or yearly. The marathon runners and joggers did not differ substantially 
fi’om the inactive subjects in their reported dietary habits, although they had significantly 
higher HDL-cholesterol levels. The positive relation between distance running and HDL 
cholesterol was significant. The distance ran was the best predictor o f  both HDL 
cholesterol and the ratio o f  HDL to total cholesterol Concluding that it is primarily the 
jogging and running, rather than diet that elevated HDL to a level associated with 
significant reduction o f coronary risk (Hartung, Foreyt, Mitchell Vlasek & Gotto, 1980).
Hartung, Squires and Gotto (1981) found similar results in studying the effects of 
chronic exercise training on plasma HDL cholesterol on 18 male coronary patients. 
Exercise training was conducted three times weekly for 20 minutes, increasing to 40 
minutes per session at an intensity utilizing 70% to 85% o f the maximal heart rate for a 
period o f 3 months. None o f  the patients were placed on a specific diet. Blood was 
drawn at the start o f the study ft) Ho wing a 12 to 14 hour fast and then again at the end of 
the 3 months. Hartung found similar results fi’om the previous study he conducted a year 
earlier. Moderate physical activity ft)r 3 months can contribute to increases in HDL-C in 
patients with coronary artery disease without dietary intervention or significant change in 
total cholesterol triglycerides and body weight (Hartung, Squires & Gotto, 1981).
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Regular participation in physical activity as well as single exercise session can 
alter lipoprotein metabolism, plasma lipid and lipoprotein concentrations and lipid 
transport (Durstine & Haskell, 1994). The understanding of the precise mechanisms 
responsible for these changes is not totally clear. There is evidence indicating that other 
factors including diet composition adiposity, weight loss, plasma volume change, and 
hormone and enzyme activity interact with exercise to alter the rates o f  synthesis, 
transport and clearance of lipid and lipoproteins from the blood (Durstine & Haskell,
1994).
Lipoprotein Lipase (LPL) is responsible for delipidation of chylomicron and 
VLDL molecules and promotes the clearance o f  fatty acids and glycerol from the 
vascular compartment for either storage or use as substrate in energy metabolism 
(Durstine & Haskell, 1994). Cross-sectional studies indicate that endurance-trained 
runners at rest have higher plasma concentrations o f  LPL activity than less active controls 
(Thompson et al., 1991). Inactive men, after undergoing endurance-exercise training, 
usually have significantly lower adipose tissue and LPL activity than compared to their 
adipose tissue when they were inactive. (Peltonen, Mamiemi, Hietanen, Vuori & 
Ehnholm, 1981).
Studies evaluating a single exercise session indicates that it increases LPL 
activity. Depletion o f intramuscular triglyceride stores by endurance exercise may 
promote secretion and/or synthesis o f  LPL by muscle cells (Oscari, Essig & Palmer, 
1990). Kanter, Cullinane, Sady, Herbert and Thompson (1987) studied 21 trained and 
untrained men on the effect o f a single exercise session on lipid and lipoprotein 
concentrations and on plasma lipoprotein lipase. After the trained and untrained subjects
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performed a single prolonged session o f  endurance cycling exercise both groups had 
higher LPL activity.
Studies show that increased LPL activity results in increased HDL synthesis and 
also indicates that exercise training also prolongs the survival o f  HDL (Durstine & 
Haskell 1994). The survival time o f  HDL protein was 27% longer in the circulation o f 
physically active men, compared with inactive men (Herbert, Bemier, Cullinane, 
Edelstein, Kantor & Thompson, 1984). Endurance training increases the half-life of 
apoliproteins A-I and A-H in active men (Thompson et al., 1988). Researchers have 
concluded the increase o f HDL associated with endurance training is a result o f  both 
increased synthesis and survival.
Other factors should be considered when evaluating the impact o f  a single session 
o f  exercise or exercise training on lipoprotein metabolism. Controversy exists about the 
effect of dietary modification on lipoproteins (Sacks et al., 1975). Some researchers have 
suggested that moderate alcohol intake or caloric restriction resulting in weight loss may 
elevate HDL (HuUey, Cohen & Widdowson, 1977). Reduced body fat and increased 
leanness are important outcomes o f exercise training. Leanness has been associated with 
lower hepatic lipase activity in physically active people (Wood & Stefenick, 1990). 
Increasing one’s exercise and changing one’s diet will help reduce body fat and prevent 
the incidence o f high cholesterol and occurrence o f heart disease.
The adipose distribution shown by waist-to-hip girth ratio (WHR) is associated 
with altered lipoproteins (Durstine & H askell 1994). Abdominal adiposity with a WHR 
greater than 1.0 in nonobese males is associated with lower HDL-C concentration 
(Barakat, Burton, Carpenter, Holbert & Israel 1980). Studies have shown subjects with
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abdominal adiposity to have plasma LDL characteristics that look almost identical to the 
LDL plasma o f subjects with CAD (Peeples, Carpenter, Israel & Barakat, 1989). This 
may suggest, as a result o f endurance training, a selective loss o f abdominal fat versus 
other areas (gluteal), a reduction in the WHR could perhaps reduce CAD risk (Peeples et. 
a l  1989).
Physical activity has a positive effect on the lipid and lip>oprotein concentrations. 
In normal men and women increased physical activity is associated with lower plasma 
triglyceride concentrations (Durstine & Haskell, 1994). The dominant changes in 
lipoproteins associated with endurance training are increased HDL-C, HDL2-C and 
apoliprotein A-I concentration (Durstine & Haskell, 1994). Exercise-induced reductions 
in LDL-C are only minor without change in adiposity or dietary fat cholesterol intake 
(Durstine & Haskell 1994).
Cholesterol Lowering Drugs
Patients whose LDL cholesterol levels remain high even with extensive dietary 
therapy and exercise should be considered for drug treatment. Dietary therapy should be 
at least six months long before drug treatment is started (The Expert Panel 1988). 
Individual with elevated LDL cholesterol levels above 220 mg/dl and/or with confirmed 
coronary heart disease, diet and exercise should not be the only therapy considered (The 
Expert Panel 1988). After the required six months o f  dietary therapy, to establish 
adequate baseline values, drug therapy should be initiated. (The Expert Panel 1988).
There are about fourteen types o f  cholesterol lowering drugs, which are grouped 
into categories based on their action. Bile acid sequestrates: cholestyramine and 
colestipal action binds acids in the GI tract, forming an insoluble complex resulting in
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increased clearance o f  cholesterol binded to bile acids eliminated in the feces. Some o f 
the most common side effects are nausea, constipation, abdominal discomfort, rashes and 
skin irritations (Hopfer, 1995).
Nicotininc acid generally known as Niacin helps lower cholesterol levels by 
decreasing lipoprotein and triglyceride synthesis by inhibiting the release o f free fatty 
acids from adipose tissue and decreasing hepatic lipoprotein synthesis. Generally it 
decreases blood lipids. Some major side effects are nausea and flushing o f the face and 
neck (Hopfer, 1995).
Fibric acids: clofibrate, fenofibrate, gemfibrozil and benzafibrate works by 
decreasing triglyceride production by the liver and increases HDL lipoproteins. Major 
side effects consist o f  diarrhea and abdominal pain (Hopfer, 1995).
Probucol is one o f  the most common cholesterol drugs prescribed to date. It may 
decrease transport o f  cholesterol from intestine or interfere with cholesterol synthesis. 
Also it may increase fecal excretion o f cholesterol and bile acids. The most common side 
effects are diarrhea, bloating, abdominal pain, nausea and vomiting (Hopfer, 1995).
There are four HMG-CoA reductase inhibitors available on prescription in the 
United States. Pravastin (provachol), Fluvastatin (lescol), and two of the newest and 
most common prescribed Lovastatin (mevacor) and Simvastatin (zocor). Also known as 
“statins” these agents slow the progression o f  coronary artery disease and have actually 
been shown to induce regression o f artherosclerotic lesions in CAD patients (Pedersen,
1995). These drugs act by inhibiting the hepatic enzyme HMG-CoA reductase, which 
leads to an increase in the hepatic production o f  cholesterol receptors. These receptors 
pull cholesterol out o f  the blood stream, thus reducing serum cholesterol levels
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(Thompson et al.,1995). Statins have been associated with some skeletal muscle 
con^laints (myositis and rhabdomyolysis). The most common side effects include 
headache, abdominal pain, constipation, and diarrhea (Kobashigawa et al., 1995).
Patients should incorporate diet, weight control, exercise and stop smoking to 
lower cholesterol levels and the risk of CHD before any drug therapy is considered 
(Expert Panel, 1993). I f  these methods fail and cholesterol levels are not lowered drug 
therapy should then be considered.
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Summary
Cholesterol is probably the best known sterol, which is essential to the human 
body. It is found associated with the fats, but chemically it is not related to them. 
Cholesterol, a  white waxy solid, is the principal sterol found in animal organisms. The 
largest amount o f  cholesterol is found in muscle, nervous and connective tissue. It is 
needed to synthesis vitamin D, cholic acid which is part o f büe, some hormones, and 
cortisol which promotes glucose synthesis in the liver. The daily production is 
approximately 400 mg from intestinal absorption and 600mg synthesized in the cells and 
the Uver. In the human body every cell, except a mature red blood ceU, produces 
cholesterol
The synthetic process o f cholesterol takes place in the liver and may occur in 
other organs. In all tissues expect in the brain, cholesterol is continually regenerated. If  
any organ can be singled out as the single most important to metabolize cholesterol and 
some amount o f  plant sterols, it is the liver. It can both synthesize and destroy 
cholesterol. The breakdown and lose o f  cholesterol can occur in four ways:
1. By direct reduction to dihydrocholesterol or by passage through the 
intermediate cholesterone to dihydrocholesterol or coprosterol
2. By loss o f  cholesterol in the feces.
3. By conversion into steroid hormones.
4. By conversion to bile acids in the liver.
There are a number o f variables that are important in determining or changing the level o f 
blood cholesterol in the body. Throughout the day the level o f  serum cholesterol remains 
for the most part constant, even through there is a  large variation in the rate that
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cholesterol enters and leaves the body. Females at birth have slightly higher levels o f  
plasma cholesterol than males. During childhood, adolescence and early adulthood there 
is very little difference in blood cholesterol between men and women. In later life males 
tend to have higher serum cholesterol levels due to higher concentrations o f VLDL and 
LDL. Serum cholesterol levels tend to be a lower in premenstrual women. After the age 
o f  50 male cholesterol levels tend to lower whereas females tend to rise slightly.
Artherosclerosis is the major disease affecting the heart and blood vessels, and is 
the leading cause o f death among middle-aged adults in the United States. 
Artherosclerosis is the result o f fatty cholesterol deposits in blood vessels walls, reducing 
elasticity and eventually blocking blood flow. It is a disorder o f the coronary arteries, 
cerebral arteries, iliac and femoral arteries and aorta that is responsible for coronary heart 
disease, stroke and peripheral arterial disease.
Treatment o f high cholesterol begins with dietary treatment. There is evidence 
indicating that dietary fiber has important hpid lowering effects and may reduce risk of 
CHD. Increasing dietary fiber intake is an important therapeutic treatment for other 
specific conditions besides CHD, such as diabetes, hyperlipidemia, hyperglyceridemia, 
hypercholesterolemia and intestinal disorders. Soluble fiber has been shown to reduce 
blood cholesterol levels. Soluble fiber increases the fecal excretion o f bile acids, which 
may alter the quantity o f  cholesterol absorbed by the intestine. The fibers fi’om firesh 
fruits, vegetables, legumes, oat bran and barley appear to have the most significance for 
reducing cholesterol levels.
Individuals who engaged regularly in cardio-respiratory activities are leaner and 
more physically fit in general than sedentary individuals. They also cholesterol (HDL-C)
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and lower concentrations o f total cholesterol, low-density lipoprotein cholesterol (LDL- 
C), very-low-density lipoprotein cholesterol (VLDL-C) and triglycerides than sedentary 
control subjects- Regular participation in physical activity as well as a single exercise 
session can alter lipoprotein metabolism, plasma lipid and lipoprotein concentrations and 
lipid transport. The understanding o f the precise mechanisms responsible for these 
changes is not totally clear. There is evidence indicating that other factors including diet 
composition adiposity, weight loss, plasma volume change, and hormone and enzyme 
activity interact with exercise to alter the rates o f  synthesis, transport and clearance o f 
lipid and lipoproteins from the blood.
Patients who cholesterol levels do not lower with dietary and exercise therapy 
drug intervention should be considered as a method o f lowering these high levels. There 
are fourteen types o f  cholesterol lowering drugs which are grouped into categories based 
on the action they perform in the body; bile acid séquestrants, nicotininc acids, Fibric 
acids, probucol and HMG-CoA. The goals o f  drug therapy are to lower total cholesterol, 
raise HDL’s and lower LDL’s. However, there are several major side effects. They 
range from itching o f  the skin, gastrointestinal distress, liver toxic effects, muscular 
damage due to interaction between drugs and blood clots.
In summary, coronary heart disease (CHD) is the leading cause o f death in the 
United States (JAMA, 1995). While factors such as obesity, diabetes, smoking, 
sedentary living and hypertension have been shown to influence CHD risk, serum 
cholesterol seems to have the strongest correlation with CHD (Genest & Cohn, 1995). 
The real aim o f  any cholesterol management intervention is to lower circulating 
cholesterol fractions. The National Cholesterol Education Program Guidelines state that
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exercise along with a high fiber diet, weight loss and medication should be included in 
the management o f high cholesterol filetions. It is important to know not only the 
interactive effect o f exercise and diet on lipoprotein metabolism but also the interactions 
between exercise and various classes o f  lipid medications now used in treatment.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTERS
METHODS
Subjects
Fifty (50) male and female subjects volunteered to participate in this study. 
Twenty-five were exercising regularly in a  supervised exercise program and the other 25 
were sedentary. The twenty-five exercising subjects belonged to two formal exercise 
programs. Twenty were from the Adult fitness program at the University o f  Nevada Las 
Vegas (UNLV). This program starts at a low level o f intensity and progresses in intensity 
each week. Subjects meet as a group five days a week Monday through Friday. The 
supervised exercise program consists o f  four components: 1) warm-up and stretching, 2) 
strength and muscular endurance, 3) cardiovascular or aerobic, and 4) cool down. The 
warm-up period includes 5 to 7 minutes o f  flexibility exercises, consisting o f bending, 
stretching and twisting. Exercises for muscular strength and endurance include push-ups, 
sit-ups and chest raising. For the aerobic pwrtion o f  the class the women do bench steps 
and jogging, and the men do bench steps and swimming. The final part o f  the program is 
a cool down period; these exercises are similar to the warm up exercises. The other five 
were participating in their own exercise program at least 3 times a week for duration of 
30 minutes and at an intensity o f 70 % or more o f  their max heart rate. The twenty-five 
sedentary subjects were recruited from the Las Vegas community and the UNLV faculty
40
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and staff. All subjects had an LDL-C o f  130 mg/dl or higher and were not on any 
cholesterol lowering medications. This study was approved by the Institutional Review 
Board (See Appendix B).
Research Design
The study was divided into a pre-experimental period, an experimental period and 
a post experimental period.
1). The 7 day pre-experimental period was for collecting baseline data.
2). The experimental period was 90 days in duration during which time the subjects 
ingested the experimental fiber.
3). The post-experimental period was when final testing was done.
There were three testing periods. Test 1 (T l) during the pre-experimental period. Test 2 
(T2) 45 days after starting the experimental period and Test 3 (T3) test during the post- 
experimental period.
Statistical Design
This study was a 2 (Group) by 3 (Time) mixed model with repeated measures 
design with exercise being between subjects and time being within subjects. The two 
levels o f exercise were exercise and non-exercise. The three levels o f  time were baseline, 
45 days and 90 days. The dependent measures o f interest were Total Cholesterol, Low- 
Density lipoproteins (LDL’s) and High-Density lipoproteins (HDL’s).
Procedure 
Pre-experimental Period 
During this period o f approximately one week the testing (T l) included a 12-hour 
fasting blood sample. A lipid profile determined Total Cholesterol, HDL-C, LDL-C,
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VLDL-C, Cholesterol/HDL Ratio and Triglycerides. This lipid profile served as their 
baseline blood profile if  it was greater than 130 mg/dl. Since an LDL-C greater than 130 
mg/dl was required to be in the study. If  the LDL-C was less than 130mg/dl they were 
eliminated fi-om the study. During this pre-experimental period, subjects were briefed on 
the study, questions were answered and they read and signed an informed consent form 
(Appendix B). Written information about Bios Life 2 was distributed to subjects 
(Appendix A). Height and weight was measured and Body Mass Index was calculated. 
Waist girth and hip girth were measured firom which a waist to hip ratio was calculated. 
Body fat was determined by bioimpedance analysis. A six-minute walk test was 
administered. The six-minute walk test was used to determine “fimctional exercise 
capacity”, which is defined as a patient’s ability to undertake physical demanding 
activities encountered in everyday life that are not reflected by conventional exercise 
testing.
Experimental Period 
During this 90-day experimental period the subjects in the exercise group 
exercised a minimum o f three times a week and took the prescribed dosage of Bios Life
2. The non-exercise group took the prescribed amount o f Bios Life 2 and did not change 
their regular routine or eating habits. After 45 days all tests (T2) were repeated exactly as 
performed in T l . This was Test 2 (T2).
Post-experimental Period 
During this period all tests were again administered: Test 3 (T3). Test T3 was 
administered as soon after the experimental period as possible. However, the subjects 
continued the experimental protocol until they were tested.
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BiosLife 2
BiosLife 2 is a dietary fiber in the form o f  a powder and packaged in 4.5-gram 
packets. It was mixed with eight-ounces o f water or finit juice and one packet was taken 
twice per day. It was taken 15 minutes prior to breakfast and dinner. (See appendix A  for 
ingredients). A  dietary survey was completed on all subjects to determine the amount o f  
fiber in their normal diet. (Appendix C). I f  the diet was low in fiber subjects were 
introduced to the Bios Life supplement gradually by taking one-half the normal dose for 
the first three to four days. Subjects reported to the laboratory every two weeks during 
the experimental period. During this time weight was taken and questions were asked 
about the subject’s adherence to the experiment protocol and reported any side effects o f  
the Bios Life. Every two weeks the subjects brought back their used and (any unused 
packages) fi-om the prior two weeks. This was used to determine compliance.
Six-minute Walk Test 
To determine a level o f  cardio-respiratory fitness a  submaximal six-minute walk 
test was given. The six-minute walk test was done on a measured course. The distance 
covered in six minutes was recorded and conqiared to national norms. The number o f  
stops (or rest periods) during the walk were also recorded. The outdoor course, where the 
test was administered, was on a concrete walkway and consisted o f 283 feet and 8 inches 
per lap. In the center o f the course was a courtyard, which was surrounded by concrete 
benches. These benches not only served as course markers they also provided a place to 
sit i f  a rest was needed. The subjects were encouraged to walk as far as they could in the 
6-minute period but were allowed to stop and rest if  necessary. The distance and the 
number o f stops were recorded for each subject.
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Anthropometrical Measurements 
Height was taken without shoes with an anthropometer to the nearest quarter o f  an 
inch. Subjects were instructed to stand as tall as possible, feet together and looking 
straightforward. Weight was measured, without shoes and minimal clothes, on a 
physicians balance scale to the nearest quarter o f  a pound. Body Mass Index was 
computed from formula o f  body weight in kilograms divided by height in meters squared 
(BW (kg)/HT (m)^). Men with a BMI greater than 27, and women with a BMI greater 
than 26.9 were considered overweight. (Appendix E). Waist girth was measured in 
centimeters at the narrowest circumference and hip girth was taken at the largest 
circumference. A waist to hip ratio o f  greater than .9 was considered obese (See 
appendix E for risks).
BMI and waist to hip ratio are commonly used in epidemiology studies to 
describe the degree o f  fatness in a population. Although these measurements were taken 
at T l, T2 and T3 they are measurements that do not usually reflect body composition 
changes in an individual over time, but were used to describe the population.
Bioimpedance Analysis (BIA)
Bio impedance analysis was done using the Bio Analgesics system A low-grade 
electric current is passed through the body, which is resisted, by body water. This 
resistance is measured in Ohms. This resistance is used in an equation to determine total 
body water. Total body water is then used to calculate per cent body fet.
Cholestech LDX
The cholestech LDX Analyzer is a  small size (5”x 5” x 8”) lightweight (21b) 
instrument designed for point o f  service lipid analysis. The analyzer uses a disposable
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cassette that needs only 35 uL blood sangles, which can easily be obtained by a 
fingerstick. The cassette contains a well into which the blood is pipetted, a glass fiber 
screen, four optical windows, a reagent impregnated bar allowing four separate reactions 
and a magnetic code bar to communicate with the analyzer. The blood is separated by 
the glass fiber screen that allows only the plasma into a reservoir. The system than uses 
reflectance photometry to obtain lipid results. The instrument has a display window that 
guides the user and displays the results, which are available within four minutes 
(Drimmer et al., 1995).
Optics Check Cassette Test Procedure 
Before any procedure is performed the analyzer must be tested. The Cholestech 
Optics Check Cassette should be ran once each day before patient samples are tested and 
after the cholestech L.D.X System has been moved or serviced. One should never use the 
Cholestech L.D.X Optics Check Cassette that has become damaged or altered in anyway. 
The cassette is placed in the analyzer and the test is run. The analyzer will automatically 
perform the optics check. Once the test is complete four numbers will appear on the 
screen and if they are within the acceptable range (80-105) a blood sample can be ran.
Performing a Fingerstick 
The patient was asked to sit quietly for five minutes before the blood sanple was 
taken. Gloves were worn while working with the blood sample and the samples were 
placed into the biohazard box when the test was completed. A capillary plunger was 
placed into the end o f a cholestech capillary tube with the red mark and set aside. To 
help increase blood flow, the fingers and hands were warm to the touch. I f  not the 
capillary puncture was done on center fingers that has been thoroughly cleaned with an
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alcohol swab. The area was thoroughly dried with a gauze pad before pricking the finger. 
Then the center fingers were firmly pricked with the lancet. The finger was squeezed 
gently to obtain a  large drop of blood. The first drop o f blood was wiped away due to the 
fact it may contain tissue fluid. The finger was gently squeezed again while holding it 
downward until a  second large drop of blood forms. The puncture should provide a firee- 
flowing drop o f blood. The capillary tube was held horizontally by the end with the 
plunger, then touched to the drop o f  blood without touching the skin. The tube will fill 
by capillary action up to the black mark. A very important step is not to collect air 
bubbles. The excess blood was wiped off and then the patient applied pressure to the 
puncture until the bleeding stopped.
Performing the Test
The fingerstick sample was analyzed within 5 minutes after the collection or the 
blood wUl clot. The cassette was taken out of the refiigerator and warmed up to room 
temperature for 10 minutes before opening. The Analyzer is plugged in and warmed up. 
The cassette was removed from its pouch and held by the short sides only. Do not touch 
the black bar or the brown magnetic stripe. The cassette was placed on a flat surface. 
Press run on the analyzer first so that a self-test can be ran. Once a Self-Test is ok the 
cassette drawer will open and load cassette will appear on screen. Use the Cholestech 
capillary tube to place sample into the test cassette sample well. Keep the cassette level 
after the sample has been applied. Immediately place the cassette into the drawer o f the 
analyzer. The black reaction bar must free toward the analyzer. The brown magnetic 
strip must be on the right. By pressing run the drawer will close and the testing begins. 
When the test is conqileted, the analyzer will beep and the screen will display the data.
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Everything that came into contact with blood including the cassette was placed into a 
biohazardous container. The results were recorded on the appropriate form.
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RESULTS & DISCUSSION
Mean total cholesterol and low-density lipoproteins were analyzed using a 2 
(group) by 3 (time) analysis o f  variance (ANOVA) procedure with repeated measures on 
the second factor. All statistical analysis was done using the SAS system.
Total Cholesterol
The test for interaction was not significant F = 0.00, p = .9985. The ANOVA did 
however yield a significant main effect for time, (F = 18.29, p = .0001), with means for 
the exercise group being 242, 233,222 and the means for the non-exercise group being 
246, 237, 226 for baseline, 45 days and 90 days, respectively (see figure 1). Tukey’s test 
was used to determine the nature o f the difference. This indicated a significant decrease 
in total cholesterol at each measure baseline, 45 and 90 days in both exercising and non­
exercising groups.
The ANOVA did not yield a significant main effect for group, (F = 0.20, p = 
.6540), with means being 232, 236 for exercise and non-exercise, respectively (see figure
2). Therefore, there was a significant decrease in total cholesterol for the exercise and 
non-exercise groups, but there was no significant difference between exercise and non­
exercise.
48
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Low Density Lipoprotein Cholesterol 
The test for interaction was not significant F = 0.72, p = .4896. The ANOVA did 
however yield a significant main effect for time, (F = 21.60, p = .0001), with means for 
the exercise group being 161, 154, 139 and the means for the non-exercise group being 
151,144, 135 for baseline, 45 days and 90 days, respectively (see figure 3). Tukey’s test 
was used to determine the nature of the difference.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
50
Figure 3 
LDL Cholesterol over Time
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This indicated a significant decrease in LDL cholesterol at each measure from 
baseline to 90 days in both exercising and non-exercising groups. The ANOVA did not 
yield a significant main effect for group, (F = 1.59, p = .2128), with means being 151, 
158 for exercise and non-exercise respectively (see figure 4). Therefore, there was a 
significant decrease in LDL cholesterol for the exercise and non-exercise groups, but 
there was no significant difference between the exercise and non-exercise.
Figure 4 
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High Density Lipoprotein Cholesterol 
The test for interaction was not significant (F = 1.06, p > 0.05). The ANOVA did 
not yield a significant main effect for time, (F = 1.67, p>0.05), with means for the 
exercise group being 51, 49, 46 and the means for the non-exercise group being 54, 52,
53 for baseline, 45 days and 90 days, respectively (see figure 5).
Figure 5 
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Therefore, there was no significant difference in the HDL cholesterol levels from 
baseline to 45 days, from 45 days to 90 days and from baseline to 90 days in both 
exercising and non-exercising groups. The ANOVA did not yield a significant main 
effect for group, (F = 1.07, p>0.05), with means being 49, 53 for exercise and non­
exercise, respectively (see figure 6). Therefore, there was no significant difference in 
HDL cholesterol for the exercise and non-exercise groups, nor was there a significant 
difference between exercise and non-exercise.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
52
60 -,
-  50 2
î  40 
J  30
j  20 -IO
z  10 
0
Figure 6 
HDL Cholesterol and Exercise Group
Exercise Non-Exercise
H Baseline 
■  45 Days 
□  90 Days
In the present study, serum total cholesterol and low-density lipoprotein 
cholesterol was significantly reduced in both exercise and non-exercising groups after 
taking three months o f  the dietary fiber supplement. Total serum cholesterol 
concentrations in the exercise group were reduced by 7.96%, and in the non-exercise by 
7.84%. Low-density lipoprotein concentrations in the exercise group were reduced by 
13.3% and in the non-exercise group decreased by 10.46%. Similar reductions in total 
cholesterol have been reported in other studies using insoluble fibers, such as pectin, guar 
gum, psyllium, legumes, oat bran and locust bean gum. Van Horn, Liu, Parker, Emidy, 
Liao, Pan, Giumetti, Hewitt and Stamler (1986) supplemented the diet o f healthy 
volunteers on a low-fet diet with 4g soluble fiber from either oatmeal or oat bran. Serum 
total cholesterol was reduced by 5% after 6 weeks on just a low fet diet and an additional 
3% reduction after 6 more weeks after adding either oatmeal or oat bran (Van Horn et al., 
1986). Jensen, Spillar, Gates, Miler and Whitman (1993) also foimd similar findings 
with patients who took a mixture o f  guar gum, pectin, psyllium and locust bean gum
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three times a  day and the subjects experienced a 10% reduction in serum TC and a 14% 
reduction in serum LDL (Jensen et aL, 1993).
Total cholesterol and serum LDL cholesterol were lowered in both the exercise 
and non-exercise groups without significantly afifecting serum HDL cholesterol levels. In 
the exercise group serum HDL levels were reduced by 8.42% and 1.63% ia the non­
exercise group. This was also observed by Anderson and associates (1992) who studied 
44 hypercholesterolemic male and female participants. After one week baseUne period, 
subjects were assigned to consume either 114g per day o f a psyllium-flake or wheat bran- 
fiake cereal ft>r 6 weeks. Fasting HDL cholesterol levels did not change significantly 
during the six weeks (Anderson et al., 1992). In a similar study Anderson (1984) also 
ft)und that in thirty-five hypercholesterolemic men with total cholesterol higher than 260 
mg/dl who were placed in either a oat bran diet, dried bean diet or canned bean diet for 
21 days. Twelve participants were placed in the oat-bran diet which the consumed 
between 50 to 100 g o f oat bran daily as hot cereal or oat bran muffins. Eleven 
participants were placed in the dried bean diet group, which they consumed 100 g o f navy 
or pinto beans served in soup. The last twelve participants were placed in the canned 
bean diet in which they consumed 120 g o f canned beans from Campbell’s Pork and 
Beans. HDL cholesterol concentrations had a non-significant decrease o f 6% as for the 
dried and canned beans there was a significant decrease in HDL concentrations.
In this study the effect o f  the exercise on the participant’s total, low-density 
lipoprotein, and high-density lipoprotein serum cholesterol levels was also of interest. It 
has been well documented that individuals who engaged in regular cardiovascular 
concentrations that place them at low risk for developing coronary artery disease. Studies
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demonstrating this lower risk include the results o f  world class marathon runners having 
exceptionally high plasma HDL cholesterol and relatively low total cholesterol, LDL 
cholesterol and triglyceride concentrations. These findings indicate that individuals who 
participate in regular strenuous exercise achieve increases in HDL levels helping reduce 
the risk o f  cardiovascular disease. Huttunen, Lansimis, Voutilainen, Ehnhohn, Hietanen, 
Penttila, Siitonen and Raurama (1990) reported a significant increase in HDL cholesterol 
by 19%, whereas plasma total cholesterol, LDL cholesteroL and triglyceride levels were 
decreased by 10% in a group o f middle-aged men who performed aerobic exercise 3 to 4 
days a week for 16 weeks.
Analysis of data from the present study shows that participants performing regular 
aerobic exercises three times a week for a  duration o f  30 minutes and at an intensity o f  
70% or more o f their predicted max heart rate had no greater decrease in lipid serum 
concentrations then those in the non-exercising participants. As shown in figure 1 and 2 
total cholesterol decreased 7.96% in the exercising group and 7.84% in the non­
exercising group and LDL decreased 13.3% in the exercise group and 10.46% in the non­
exercising group. HDL concentration decreased 8.42% in the exercise group and 1.63% 
in the non-exercise group (see figure 3). Generally, when a person’s lipid levels are high, 
regular exercise training can usually reduce high levels o f  total and LDL cholesterol. The 
exercise group’s lack o f  response to have an even larger decrease in total and LDL 
cholesterol concentrations when compared to the non exercise group might be explained 
by the feet that each participant in the exercise group had been exercising for 6 months or 
longer before entering the study. One might hypothesis that they may have already 
lowered their cholesterol levels to the extent in which exercise can affect them Dietary
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therapy in conjunction with regular exercise is considered an essential element in therapy 
o f  elevated serum cholesterol levels. In this study, patients at risk for coronary heart 
disease exhibited significant reductions in serum cholesterol after using Bios Life.
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CHAPTERS
SUMMARY AND CONCLUSIONS 
Summary
An increase in the incidence o f coronary heart disease has lead to an increased 
interest in preventive measures. Since there is a strong relationship between high fiber 
diet, regular exercise and coronary heart disease, health professionals support a high fiber 
diet and regular exercise as a contributing factor in reducit^ this incidence.
It has been well documented that both high levels o f  total serum cholesterol and 
specifically low-density lipoproteins are linked with coronary heart disease. 
Epidemiological data from the Framingham Heart Study indicate that elevated total 
serum cholesterol is a major coronary risk factor. Larosa and associates (1990) studied 
CHD histoiy and total cholesterol in 2,282 men and 2,845 women and concluded that 
there was definite evidence that high levels o f total cholesterol were associated with an 
increase in the incidence o f  CHD and that conversely low levels o f  total cholesterol were 
associated with a low incidence o f  CHD (Larosa et al., 1990).
The general purpose o f dietary fiber supplementation as therapy is to reduce 
elevated serum cholesterol levels. This is achieved primarily by reducing fet intake and 
consuming a healthy diet, rich in fiber. Dietary therapy in conjunction with regular 
exercise is considered an essential element in therapy o f  elevated serum cholesterol
56
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(Ready, 1996). Exercise has been shown to help in the promotion o f  weight reduction, 
which enhances LDL cholesterol lowering, reducing triglyceride, raising HDL, reduces 
blood pressure and decreasing the risk o f diabetes mellitus. Therefore, the combination 
o f  regular exercise and diet rich in fiber can lower total cholesterol, increase HDL, 
decrease LDL and consequently reduce the risk o f  CHD.
The purpose o f this study was to investigate the effects o f  Bios Life, a non­
prescription dietary fiber supplement, on Total and LDL cholesterol and determine 
whether exercise accentuates this effect. Fifty (50) male and female subjects volunteered 
to participate. Twenty-five were exercising regularly in a supervised exercise program 
and the other 25 were sedentary. A 12-hour fasting blood sample was taken prior to the 
study to obtain a baseline value and again at 45 and 90 days. Subjects had to have LDL- 
C greater than 130 mg/dl to participate in the study. Both groups took 4.5 gram packets 
of Bios Life twice a day. Neither group changed their regular routine or eating habits.
Mean total cholesteroL low-density Upoproteins and high-density lipoproteins 
were analyzed using a 2 (group) by 3 (time) analysis o f  variance (ANOVA) procedure 
with repeated measures on time. All statistical analysis was done using the SAS system.
The results o f this study showed that total cholesterol and low-density 
lipoproteins concentrations decreased significantly from baseline to 90 days. This was 
true whether or not the subject was in the exercise group or non-exercising group. 
Conclusions
The following conclusions can be drawn from this study:
1. Exercise did not accentuate the effect o f Bios Life.
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Recommendations
The following are recommendations for future studies:
1. Since there was no significant difference between the exercise and non-exercise 
groups it is suggested that the participants in the exercise group not be involved in an 
exercise program prior to the study. Both groups should take the Bios Life, but the 
participants in the exercise group start an exercise regimen at the beginning o f  a 
study.
2. Bios Life did decrease total cholesterol and LDL levels over the 90 days but not to the 
same extent as some o f  the other drugs like probucol, niacin, pravastin, and zocor. As 
reported in the existing literature, further research over a greater amount o f  time may 
be needed to see if  time would allow for a greater decrease in total cholesterol and 
LDL levels with Bios Life users.
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PURPOSE
It has been documented that high levels of total serum cholesterol have been 
linked with coronary heart disease. However, reductions in the low-density lipoprotein 
fraction of total cholesterol are linked with reduction in myocardial inferction and sudden 
cardiac death. There is evidence indicating that dietary fiber can lower serum 
cholesteroL Individuals consuming a diet high in fiber tend to have a lower incidence of 
myocardial inferction and sudden cardiac death. This study will the effects of Bios Life 2 
a dietary fiber supplement on serum IqmiHotems, and determine whether exercise 
potentates this effect.
PRODUCT
The natural dietary fiber supplement consisted o f a mixture based on a patented 
formula (# 4,824,672) and (# 4,883,788) titles "hfethod and C on^sition for Reducing 
Serum Cholesterol’ manufoctured by Rexall Showcase International under the trade name 
Bios Life Natural This patented formula consisted of pectin, guar gum, gum arable, oat 
fiber, and locust bean, gum. This product also contains various vitamins (beta carotene, 
vitamin E, vitamin C, niacinamide, vitamin B-12, pyridoxine HCl, riboflavin, thiamine 
HCl, biotin, and folic acid). In addition, diromium polynicotinate and selenomethionine 
were added to enhance the metabolic a^>ects of the product To improve palatability, 
Stevia, a natural fiber with known natural sweet effects, was added to the product mix.
METHODS
As a volunteer for this study your LDL cholesterol level must be greater than 130 
mg/dl and keep particÿating in a frmnal exercise program at least three times per week.
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You will givea 12-far. âsting blood sanq>le baseline, 30,60 and 90 days. Also at these 
time periods heigln and we^ht will be taken and Bo<fy Mass Index computed. Waist 
girth and hq>giith will be measured and waist to bq> ratio will be computed. Body fat 
will be detomined by lnoinq)edance anafysis. A six-minute walk test will be 
administered.
For the next 90 days you will mix Bios Life 2 a dietary fiber with an eight-ounce 
glass of water, fruit juice or Gatomde. It will be taken 15 minutes prior to breakfrst and 
dinner. Weekly questioning to monitor adherence to the fiba* statement will 
administoed.
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U N IV E R S IT Y  O F NEVADA, LA S V EG A S 
COLLEGE OF HEALTH SCIEN CES
DEPARTMENT OF KINESIOLOGY 
EXERCISE PHYSIOLOGY 
BOX 4 5 3 0 3 4  
LAS VEGAS, NV 8 9 1 5 4 -3 0 3 4
M E M O R A N D U M
DATE: 9/15/98_________________________
TO: ______ Subjects for Cholesterol lowering study__________________
FROM: Lawrence A. Golding. E-mail: T.AnmlHlnpfS)ani com and Lori inderiied
SU BJEC T:_____ Requirements for the study______________________________
The Exercise Physiology Laboratory Is about to  start a study on the effect o f a 
non-prescription fiber preparation, which Is claimed to reduce LDL Cholesterol. 
Total cholesterol Is m ade up o f iow-denslty lipoprotein cholesterol (LDL-C) and 
high density lipoprotein cholesterol (HDL-C). The popular literature refers to  LDL 
a s  the "bad” cholesterol and the HDL as  the "good” cholesterol.
This study will Investigate the effect of taking th is supplem ent In people who are 
exercising and in people who are sedentary. All subjects m ust have a  LDL 
cholesterol of more than 130mg/dl.
You have been Identified a s  som eone who is exercising regularly (the adult 
exercise program) but who has a LDL cholesterol greater than 130mg/dl. We 
would like you to  volunteer to  be a su b jec t 
The details of the study are a s  follows:
1. The study will be 90 days in duration.
2. A llpid profile will be done prior to the study starting, after 45 days and again at 
the end of the  study.
3. During those sam e 3 times the following m easurem ents will be taken:
I. Percent fat by Bioimpedance. This only requires two electrodes to  be 
placed on your wrist and ankle. A very low-grade electric current (from a 
9voK battery, which you will not feel) will pass between the electrodes and 
impedance will be m easured from which percent fat Is calculated. This is 
done in street clothes only requiring the right shoe and sox to be removed.
II. Height and welghL
III. Waist and hip girth
hr. A Sminute walk will be  done for time.
V. Every two weeks you will be asked to  come to the laboratory to  pick up 
your two week supply o f Blosllfe and return the empty packages from the 
previous two weeks. This is the way we document that you have taken the 
Bloslife. If you m iss a dose, simply bring back the full package and we can
Tdcplione; (702M 9S-3766 
FAX, (702)-895-4191
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record w hat you m issed. When you com e in weight will be taken and a 
modified percent fat through bioim pedance will be done. This modified 
procedure only requires you to  hold and Instrument in your hand, 
vl. Prior to  starting, you will be asked to  complete a simple questionnaire 
to  determ ine how much fiber you are presently consuming In your normal 
dally diet.
Enclosed Is an Informed consent form which explains the above. If you are
willing to  participate please sign the form, have your signature w itnessed 
and return it in the  enclosed, self addressed  stamped envelope.
Telephone; (702)-895-3766 
FAX, (702)-895-4191
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DATE: May 11, 1998
TO: Lori J. Inderiied (KIN)M/S: 3034
FROM: ' Dr. William E. Schulze
o^^'VDirector, Office of Sponsored Programs and y Member, Biomedical Sciences Committee UNLV Institutional Review Board
RE: Status of Humcui Subject Protocol entitled:"The Effect of Bios Life, a Non-prescription Cholesterol-Lowering Substance and a Combination of Bios Life and Exercise on Serum Lipids : “
OSP #504s0498-013b
This memorandum is official notification that the protocol for the project referenced above has been approved by the Biomedical Sciences Committee of the Institutional Review Board. This approval is approved for a period of one year from the date of this notification, and work on the project may proceed.
Should the use of human subjects described in this protocol continue beyond a year from the date of this notification, it will be necessary to request an extension.
If you have any questions or require any assistance, please Marsha Green at 895-1357.
cc: L. Golding (KIN-3034) OSP File
Office of Sponsored Programs 
4505 Maryland Parkway • Box 451037 • Las Vegas, Nevada 89154-1037 
(702) 895-1357 • FAX (702) 895-4242
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CONSENT TO PARTICIPATE IN RESEARCH 
UNIVERSITY OF NEVADA, LAS VEGAS 
EXERCISE PHYSIOLOGY LABORATORY
TITLE OFTHE STITDY
i The effect o f Bk>s Life axid a combination o f Bios Life and exercise on total cholesterol,
serum bw  density lipoprotein, and serum high density Iqx>piotein will be invest^ated.
PURPOSE
It has been weU documented that high fevels o f total serum cholesterol have been linked 
with coronary heart disease. However, reductbns in the b w  density lipoprotein feactbn 
 ̂ o f total cholesterol are linked with reductbn In myocardial inferctbn and sudden cardiac
death. There is evidence iixiicating that dietary fiber can bwer serum cholesteroL 
I bxlividuals consuming a diet high in fiber tend to have a bwer incidence o f nyocardial
inferctbn and sudden cardiac death. This study will mvestigate the effects of B bs Life, a 
_ dietary fiber stqrplement on serum lipoproteins, and determine whether exercise
s potentiates this effect.
y
PROCEDURES
If you decide to partbipate in this Study you will report to eifirer the Exercise Pfaysbbgy 
L Laboratory or the Cardbvascular Center of Southern Nevada fer an explanatbn of the
^ study. A six mmute walk test will be given as well as weight arxi body percent fet taken.
Four times during the study you win report to the bbod lab fer a 12 hour festing bbod 
' sarr^te to be collected. There is no cost to you as a pattbq>ant fer any tests done in this
project The details o f the study areas felbwed:
V Pretreatmem Period: A 12 hour fisting bbod sanyb will be taken fiom each
) partbqrant to determine if they fiilfiU the cholesterol arb lipoprotein criteria. The criteria
to partbqrate is ones LDL must be 130 mg/dl or greater. Orx% 50 participants are 
f identified body fet and weight will be takerL A six mmute walk wUl be administered to
determine aerobb capacity.
Treatment Perbd: The group wfil be randomly divided in two grouns: The 
R control groiç will not be exercising and wfll remain on tfaerrcurreittdiet. The
experimental grorq) win continue, their regular exercise program at least three times per 
\ week.
? Each grotq) will be instructed to consume 4.5gofB bs Life beferebreakfest and
dinner by stirring the contents o f one packet into an 8oz glass o f half water arxi half juice 
arxi drink immediately. This will be done 15 minutes prbr to Ixeakfest and dinner 
everyday fer the length o f the study. Partbipants wOl have a festing lipid panel 
conqrleted 30,60 arxi 90 days later. Also weight, aerobb capacity arxi body percent fet 
will be measured at 30,60 arxi 90 days.
RISKS
The risks o f taking B bs Life are m m im al. This is an non-prescriptive dietary siqrplement 
administered comnaonly be cardbbgists. Efowever, using this product may result in mild 
gastroirrtestinal distress, increases stool volume, Hkrrhm*, constipatbn, abdominal
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cranqnngor^ipetitesiqrpressioa Ifyou experience any ofthese side affects, please 
repent to the leseardier as soon as possible and also consult your plqrsician if  necessary.
BENEHTS
The benefits include a reduction in LDL-C and increase in HDL-C. The exercise group 
will benefit fix>m the physical effect o f exercise, and the value o f  exercise combined with 
ingestion o f Bios Life win be known.
COWFTDENTf ALITY
Your particpetionm and the results o f this study wiUremamconfidentiaL On^ those 
parties dhectfy related whh the coUection and analysis o f data wfll have access to your 
file. Iffhe data is presented in a scientific journal or conférence you wOl be referred to 
by aparticipam number not your name.
RIGHT TO REFUSE OR WITHDRAWAL
Your particpation in this sturfŷ  is strictfy voluntary. You nay withdraw consent or 
refiise to participate at any tinae.
QUESTIONS
Any questions you have about the study it's purpose, dmagn, methodology, procedures 
arxi significance will be addressed to your satisfictioa If you have additioral questions 
please feel fiee to contact Lori hxlerlied or Dr. Goldirg at 895*3766 or Chetri Epstein 
Director o f the Cardiac Rehabilitation program at 254-2400.
For questions regarding the r%hts o f research participants you rray contact the OfBce of 
Sponsored Programs at 895-1357.
You will be given a s%ned arxi dated copy o f this fimn fer you records.
I UNDERSTAND THE RESEARCH PROCEDURE AND HAVE DECIDED TO 
VOLUNTEER AS A RESEARCH SUBJECT. I HAVE READ THE PROVIDED 
INFORMATION AND ALL QUESTIONS REGARDING THE EXPERIMENT 
HAVE BEEN ANSWERED TO MY SATISFACTION. I UNDERSTAND THAT I 
HAVE THE RIGHT TO WITHDRAW FROM THIS STUDY AT ANY TIME 
WITHOUT RECRIMINATION.
Name o f Particpant (print) Signature Date
Name o f Witness ^xrint) Signature Date
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UNLV
University o f  Las Vegas Nevada 
Inderiied Cholesterol/Bios Life Study 
Instructions on Dietary Survey
For three days you wül write down everything you eat including beverages in the first 
column. In the second column you will put down the amount o f your servings. Attached 
to the dietary survey there is a helping guide, this allows you to figure out the exact 
serving size. The third column you will write down how you prepared the food. For 
example: You baked chicken in the oven. Remember to count what you might have 
marinated the chicken in and also how you coated the baking pan. The last column is for 
any comments that you might want to add for the nutritionist who wül be analyzing the 
survey.
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UNLV XwrÜMn Ptofnm 
3 Day Food Record 
(For Extrdse M r^obgy (Sulourol Study)
Xemc A*e: ,
Todav's Dale: Wdgta:
. Gender _ 
_ Heighu .
Food or Beverage Amount
Eaten
Method Prepared ConmcoK
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Junel, 1999 
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auMamanta that you may taka
We have tiighiighted the nutrtenta In your diet whioh are tMowr 
raoommandad amounta. A let of aalactod vitamin and mirwrai food aouroaa la 
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If you have any queationa regarding your reauka. pleoae c a l Dr. Suaan L 
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May 28,1999
Serviig Size: 2471.53 g (87.18 oz.) 
ScMes: 3
Cost —
%  comparisoD to : > MuM-Columm
Basic Compononts VhaamAHE 928J3RE 116%
Ctlories 1466.19 70% A-CtiMeBaid 220.04RE Fhnride -m g
PMcm 43j6g  74% A-ReHmri SS.S9RE
Caiboi^dnles 230.27g S2% TlmmmBl 1.07mg 102% Ino 14J6mg 96%
Dietmy Fiber 15.76 g 75% Megnomm 256.44 mg 92%
SohM eFta 3.95 g 1 11' i|iirillFniiW lkP71lï Mangasem 4.25 mg 121%
InSoiobieFiber 6.74g
Sagv-ToOl 147.41g P b a jto »  533.81 mg 67%
Moooacdurides 18.41 g V| _
DiaodBiides 15J8g VimmmC 320.18mg 534% Sdenmm T3T$0d ^  80%
OtherCubs 55A )g  ^UMlÊDaS^^SIBSSÊfSmH  Sodmm 1777.85 n« 74%
g g g B W B @ S S g |B K i^ |%  VkmmnEe, 5.23mg ^SBSS^^Sm msSÊSSÊÊm s^m
FoWc lS3J3mcg 102% OOMTFalS
onegi3FmtyAddi 0.63 g 
Omeg,6Fm^Ad<k 4.84g 
TmBsFanyAdds 0.06 g M m rais OOmt
Bom 0.10 s ,  Aloohol 0.47 g
Water 2014.45 g CaSdne 101.79 mg
VitHnins (IL L liliiw n rT T ag g to B B p g ^
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M in e r a ls
Calcium
Milk, cheese, related dairy products, dark green leafy vegetables, legumes (dried beans, peas), some tofu, 
almonds
Chromium
Mushrooms, prunes, nuts, asparagus, meat, organ meat (heart, kidney. Ever), whole grains, cheese 
Copper
Seafood, shellfish, organ meat (heart. Iddney. liver), whole grains, nuts, seeds, vegetables, water from copper 
pipes
Iodine
Iodized salt, some seafood, plant & animal products from fertilizers and feed, dairy products from feed 
additives and disinfectants, breads through the iodates In dough conditioners
Iron
Lean meats, fish, poultry, organ meat (heart, kidney, liver), legumes, nuts, seeds, whole grains, green leafy 
vegetables
Magnesium
Whole grains, legumes, nuts, seeds, chocolate, dark green vegetables, banamas 
Manganese
Whole grains, cereal products, tea, fruits, vegetatiles 
P hosphorus
Protein-rich foods (espedally animal protein), cereal grains, milk, milk products, meat 
Potassium
Fresh fruits: peaches, pears, cantaloupe; fresh vegetables: winter squash, potatoes, spinach, legumes, yogurt 
Selenium
Seafood, meats, eggs, whole grains, brazil nuts, legumes 
Sodium
Sodium Intake may be reduced by eating more whole grains, fresh fruits and vegetables 
Zinc
Seafood, meats, whole grains, legumes. Shellfish are higher in zinc concentration than white fish, and darker 
poultry meat has more than light meat
Dietary Jiber •
fresh fruits 4  vegetables, legumes, nuts, seeds, vhole grains, tvhale grain products
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'Vitamins
vitamin A
From plant sources (carolenoids): broccoli, swiss chard, kale, spinach, romaine lettuce, endive, carrots, sweet 
potatoes, winter squash, apricots, peaches, cantaloupes, papayas (yellow/orange vegetables and fruits). From 
retinot (animal sources): liver, fish Ever oils, margarine, milk, milk products, butter, eggs
B1- Thiamin
Whole grains, legumes (beans and peas), seeds, pork, organ meats (heart, kidney. Ever), brewer’s yeast, breads 
made with enriched white wheat flour, fortified cereals
B2-RIboflavIn
Dairy products, eggs, whole grains, fortified cereals, baked goods made with enriched white wheat flour, 
broccoli, asparagus, tumlp greens, spinach. Ever
B3 - Niacin
Meat, fish, poultry, breads made with enriched flour, fortified cereals, mushrooms, baked potatoes, peanuts 
Vitamin B6
Chicken, fish, pork, eggs. Ever, (whole grains) brown rice. oats, whole wheat products, soyt)eans. peanuts, 
avocados, bananas
Vitamin B12 
Meats, dairy products, eggs
Biotin
Kidney, Ever, egg yoik, soy flour, cereal grains, yeast 
Vitamin C
Fresh fruits & vegetables, espedatty dtrus fruits, broccoli, cauliflower, sweet & hot peppers, strawberries 
Vitamin D
Fortified processed cow’s milk and Infant formula, egg yolks, butter. Ever, some fatty fish, fortified margarine, 
sunshine
Vitamin E
Whole grains, vegetable oils, margarine, salad dressings, foods high in unsaturated fats. nuts, seeds, poultry, 
fish, eggs
Folacln/Foiate
Fresh, green, leafy vegetables. Ever, legumes, oranges, peanuts, sunllower seeds, whole grains 
Vitamin K
Green leafy vegetables, members of the cabbage family, mUk. soybean oil, egg yolks 
Pantothenic Acid
Whole grains, legumes, some vegetables and fniits, organ meats (heart, kidney. Ever), yeast, egg yolk '
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Baseline
UM EV
INDERLIED CHOLESTEROL/BIOSLIFE STUDY
DATA SHEET
TESTER_________________ DATE
SUBJECT  SUBJECT #
TESTING LOCATION  SEX M F
HEIGHT__________________INS. WEIGHT_____________LBS.
BMI_______________
BOP GIRTH________________ INS- WAIST GIRTH________________INS.
W AIST/mP RATIO___________________
BIOIMPEDANCE_______________ OHMS. ______________% FAT
BLOOD PANEL:
TOTAL____________  mg/dl HDL__________mg/dl
LDL_____________mg/dl HDL/RATTO__________ mg/dl
TRIGLYCERIDES___________mg/dl
6-MINUTE W ALK_______________ #  LAPS
NUMBER OF PACKETS OF BIOSLIFE RETURNED 
FULL EMPTY
DATE TEST STARTED
NEXT SCHEDULED APPOINTMENT. 
COIHMENTS:
C ollege  o f  H ea lth  S c ie n c e s  
D e p a r tm e n t o f  K inesio logy 
4 5 0 5  M aryland P arkw ay  •  B ox 4 5 3 0 3 4  •  L as  V eg as, N ev ad a  8 9 1 5 4 -3 0 3 4  
(702) 8 9 5 -0 9 9 6  •  FAX (702) 895 -1 5 0 0
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45 Days
I 7 N T V
INDERLIED CHOLESTEROL/BIOSLIFE STUDY
DATA SHEET
TESTER_______________ DATE
SUBJECT  SUBJECT #
TESTING LOCATION  SEX M F
HŒTGHT__________________ INS. WEIGHT_____________LBS.
BMI_______________
m P  GIRTH INS. WAIST GIRTH________________INS.
WAIST/BŒP RATIO___________________
BIOIMPEDANCE________________OHMS. ______________% FAT
BLOOD PANEL:
TOTAL_____________ mg/dl HDL__________mg/dl
LDL mg/dl HDL/RATIO___________mg/dl
TRIGLYCERIDES___________mg/dl
6-MINUTE W ALK ________________# LAPS
NUMBER OF PACKETS OF BIOSLIFE RETURNED
FULL ___________ EMPTY______________
DATE TEST STARTED
NEXT SCHEDULED APPOINTMENT. 
COMMENTS:
C o lle g e  o f  H ea lth  S c ie n c e s  
D e p a r tm e n t  o f  K inesio logy 
4 5 0 5  M ary lan d  P a rk w a y  •  B o x  4 5 3 0 3 4  •  L as V eg a s , N e v a d a  8 9 1 5 4 -3 0 3 4  
(702) 8 9 5 -0 9 9 6  •  FAX (702) 8 9 5 -1 5 0 0
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90 Days
I J N T V
INDERLIED CHOLESTEROL/BIOSLIFE STUDY
DATA SHEET
TESTER DATE
SUBJECT
TESTING LOCATION________
HEIGHT__________________ INS.
BMI
SUBJECT #  
SEX M
WEIGHT
F
LBS.
HIP GIRTH INS. WAIST GIRTH INS.
WAIST/HIP RATIO 
BIOIMPEDANCE OHMS. % FAT
BLOOD PANEL: 
TOTAL
LDL
TRIGLYCERIDES 
6-MINUTE WALK
  mg/dJ EQ>L__________mg/dl
mg/dl EDDL/RATTO___________mg/dl
_______mg/dl
#LAPS
NUMBER OF PACKETS OF BIOSLIFE RETURNED 
FULL EMPTY
DATE TEST STARTED
NEXT SCHEDULED APPOINTMENT 
COMMENTS:
C o lleg e  o f  H ea lth  S c ie n c e s  
D e p a r tm e n t  o f  K inesio logy  
4 5 0 5  M ary land  P a rk w a y  •  B o x  4 5 3 0 3 4  •  L a s  V eg a s , N ev a d a  8 9 1 5 4 -3 0 3 4  
(702) 8 9 5 -0 9 9 6  •  FAX (702) 8 9 5 -1 5 0 0
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Exercise Group
Raw Data Total Cholesterol
Non-Exercise Group
Baseline 45 Davs 90 Davs Baseline 45 Davs 90 Da
Subject 1 284 270 250 Subject 26 240 237 228
Subject 2 196 196 180 Subject 27 205 200 200
Subject 3 186 190 180 Subject 28 200 200 200
Subject 4 204 203 200 Subject 29 260 240 210
Subject 5 316 239 277 Subject 30 220 210 200
Subject 6 246 250 248 Subject 31 359 313 253
Subject 7 249 230 225 Subject 32 283 255 230
Subject 8 279 272 273 Subject 33 280 270 240
Subject 9 197 225 199 Subject 34 221 211 190
Subject 10 227 227 228 Subject 35 250 240 250
Subject 11 218 211 190 Subject 36 210 210 200
Subject 12 246 220 235 Subject 37 228 240 237
Subject 13 209 188 183 Subject 38 265 265 260
Subject 14 230 209 200 Subject 39 264 250 244
Subject 15 287 378 293 Subject 40 234 246 212
Subject 16 217 218 200 Subject 41 246 236 212
Subject 17 210 209 200 Subject 42 246 246 246
Subject 18 246 230 200 Subject 43 290 290 280
Subject 19 230 230 200 Subject 44 210 210 210
Subject 20 288 270 270 Subject 45 222 200 214
Subject 21 213 200 200 Subject 46 240 237 237
Subject 22 222 177 200 Subject 47 205 205 205
Subject 23 269 279 280 Subject 48 283 255 255
Subject 24 222 200 205 Subject 49 284 270 250
Subject 25 359 313 253 Subject 50 210 210 210
Mean 
Std. Dev. 
Std. Error
242 
41.560197 
8 J 120395
233.36
44.598094
8.9196188
222.76
35.18910816
7.037821633
Mean 
Std. Dev. 
Std. Error
246.2
36.924472
7.3848945
237.84
29.762504
5.9525009
226.92
23.891979
4.7783958
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Exercise Group
Raw Data LDL Cholesterol
Non-Exercise Group
Baseline 45 Davs 90 Davs Baseline 45 Davs 90 Davs
Subject 1 206 197 160 Subject 26 138 129 137
Subject 2 133 133 120 Subject 27 132 140 130
Subject 3 132 130 125 Subject 28 130 130 130
Subject 4 141 139 130 Subject 29 180 170 130
Subject 5 189 165 140 Subject 30 146 136 126
Subject 6 142 173 149 Subject 31 236 196 139
Subject 7 162 150 140 Subject 32 158 114 114
Subject 8 177 173 150 Subject 33 160 160 140
Subject 9 173 142 140 Subject 34 131 124 120
Subject 10 154 154 172 Subject 35 140 135 135
Subject 11 154 150 130 Subject 36 140 141 130
Subject 12 143 113 120 Subject 37 137 138 129
Subject 13 155 117 136 Subject 38 180 180 175
Subject 14 139 124 112 Subject 39 139 139 130
Subject 15 219 296 211 Subject 40 140 143 136
Subject 16 134 133 120 Subject 41 149 146 131
Subject 17 134 136 129 Subject 42 138 138 138
Subject 18 140 136 129 Subject 43 158 158 154
Subject 19 140 140 130 Subject 44 141 140 141
Subject 20 171 161 161 Subject 45 138 137 149
Subject 21 172 162 146 Subject 46 138 129 129
Subject 22 140 123 126 Subject 47 132 132 132
Subject 23 170 155 145 Subject 48 158 114 114
Subject 24 174 164 131 Subject 49 206 197 160
Subject 25 236 196 139 Subject 50 141 140 141
Mean 161.2 154.48 139.64 Mean 151.44 144.24 135.6
Std. Dev. 27.971712 36.766289 20.605177 Std. Dev. 25.270338 21.6781 13.400871
Std. Error 5.5943424 7.3532578 4.1210355 Std. Error 5.0540677 4.3356199 2.6801741
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Exercise Group
Raw Data HDL Cholesterol
Non-Exercise Group
Baseline 45 Davs 90 Davs Baseline 45 Davs 90 Davs
Subject 1 58 54 50 Subject 26 60 60 82
Subject 2 49 49 46 Subject 27 54 56 50
Subject 3 25 20 54 Subject 28 54 54 54
Subject 4 48 51 30 Subject 29 60 60 48
Subject 5 56 66 53 Subject 30 54 54 50
Subject 6 61 61 71 Subject 31 56 55 59
Subject 7 64 54 64 Subject 32 64 63 50
Subject 8 62 48 44 Subject 33 56 56 50
Subject 9 23 27 45 Subject 34 54 43 54
Subject 10 31 31 36 Subject 35 54 54 50
Subject 11 31 30 31 Subject 36 54 52 50
Subject 12 82 84 58 Subject 37 82 60 60
Subject 13 23 31 29 Subject 38 34 34 29
Subject 14 59 51 50 Subject 39 61 61 61
Subject 15 43 60 39 Subject 40 32 34 36
Subject 16 50 45 47 Subject 41 39 39 41
Subject 17 58 58 51 Subject 42 60 60 60
Subject 18 45 45 45 Subject 43 64 64 62
Subject 19 65 65 50 Subject 44 50 50 50
Subject 20 70 60 60 Subject 45 22 19 27
Subject 21 54 50 46 Subject 46 60 60 60
Subject 22 55 31 29 Subject 47 54 54 54
Subject 23 86 94 60 Subject 48 64 63 63
Subject 24 28 26 27 Subject 49 60 60 82
Subject 25 56 55 59 Subject 50 48 40 46
Mean 51.28 49.84 46.96 Mean 54 52.2 53.12
Std. Dev. 17.145262 17.747488 11.890052 Std. Dev. 12.086494 11.25833 12.80403(
Std. Error 3.4290523 3.5494976 2.3780104 Std. Error 2.4172988 2.251666 2.5608072
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PHYSICAL CHARACTERISTICS 
BODY COMPOSTION TABLES 
BODY MASS INDEX 
WAIST/HIP CIRCUMFERENCE 
W AIST/mP RATIO PERCENTILE FOR HEART DISEASE
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Exercise Group
Physical Characteristics of Participants
Sex Age Height Weight BMI Waist to Hip Ratio Bioimpedance % Fat 6-Minute Walk Test
Years Inches Pounds Ohms
Subject 1 Male 50 70 215 31 0.8 400 21.3 7 laps
Subject 2 Female 32 63 138 24.5 0.8 478 24.2 8 laps
Subject 3 Male 58 69 170 25 0.9 486 19.7 8 laps
Subject 4 Male 53 73 250 31 0.6 486 36.8 8 laps
Subject 5 Female 50 68 163 24 0.75 557 29.7 6 laps
Subject 6 Male 36 71 156 22 0.8 477 13.9 8 laps
Subject 7 Female 63 71 186 26 0.75 586 33.1 6 laps
Subject 8 Male 50 73 246 33 1 403 23 6 laps
Subject 9 Male 59 71 178 25 0.9 462 17.6 7 laps
Subject 10 Female 59 64 120 21 0.8 400 21 5 laps
Subject 11 Female 53 63 166 29 0.9 586 37.8 6 laps
Subject 12 Male 56 72 200 28 0.8 496 29 7 laps
Subject 13 Male 59 69 177 26 0.8 496 27 7 laps
Subject 14 Female 47 64 171 29 0.75 483 32.7 6 laps
Subject 15 Male 47 70 188 27 0.85 451 19.8 6 laps
Subject 16 Male 64 68 131 20 1.1 531 13.8 6 laps
Subject 17 Male 54 61 153 29 0.8 464 23.8 6 laps
Subject 18 Male 60 69 190 28 0.8 470 24.2 6 laps
Subject 19 Female 52 67 155 23 0.8 581 30.5 7 laps
Subject 20 Female 48 66 162 26 0.9 580 31 6 laps
Subject 21 Female 50 60 132 26 0.9 581 21 6 laps
Subject 22 Male 59 68 156 23 0.9 467 16.1 8 laps
Subject 23 Female 30 67 142 22 0.8 389 16.1 7 laps
Subject 24 Male 65 72 257 30 1.1 486 36 5 laps
Subject 25 Male 45 71 166 23 0.75 478 16.1 9 laps
Mean 51.96 68 174.72 26.06 0.842 490.96 24.608 6.68
Standard Dev, 9.18 3.71 36.25 3.41 0.11 60.47 7.37 1.03
Standard Error 1.84 0.74 7.25 0.68 0.02 12.09 1.47 0.21
CD■D
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Non-Exercise Group
Physical Characteristics of Participants
3
3"
CD
CD■D
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C
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C/)
Sex Age
Years
Height
Inches
Weight
Pounds
BMI Waist to Hip Ratio Bioimpedance
Ohms
% Fat 6-Minute Walk Test
Subject 26 Female 57 67 141 22 0.8 648 28.8 7 laps
Subject 27 Male 56 62 131 24 0.8 648 28.8 6 laps
Subject 28 Female 60 70 180 26 1 423 16.1 8 laps
Subject 29 Male 59 68 140 21 0.8 477 13.9 7 laps
Subject 30 Male 50 72 205 28 0.9 486 28 6 laps
Subject 31 Female 46 60 120 23 1 300 18 6 laps
Subject 32 Female 40 62 130 24 1 400 23 7 laps
Subject 33 Female 30 70 221 30 1.1 535 15 7 laps
Subject 34 Female 60 70 174 25 1.1 386 17.1 6 laps
Subject 35 Male 56 74 250 30 1.1 586 27 6 laps
Subject 36 Male 51 66 140 24 0.8 486 23 6 laps
Subject 37 Male 40 62 140 25 0.9 424 12 4 laps
Subject 38 Female 48 68 131 35 0.9 648 28.6 5 laps
Subject 39 Male 57 72 186 25 0.9 500 26 5 laps
Subject 40 Female 36 64 140 24 0.7 480 25 8 laps
Subject 41 Female 38 62 146 27 0.9 464 28.6 4 laps
Subject 42 Male 45 70 200 29 1 500 24.6 7 laps
Subject 43 Female 55 61 205 35 1 486 31.1 4 laps
Subject 44 Female 39 58 150 30 I 486 26.7 7 laps
Subject 45 Male 36 67 166 25 0.9 423 16.1 8 laps
Subject 46 Female 57 64 154 26 0.7 646 28 7 laps
Subject 47 Male 52 67 283 40 1.2 537 34.4 7 laps
Subject 48 Female 44 64 126 21 0.7 648 28.8 8 laps
Subject 49 Female 30 67 142 22 0.8 389 16.1 7 laps
Subject 50 Male 59 68 156 23 0.9 467 16.1 8 laps
Mean 48.04 66.2 166.28 26.56 0.916 498.92 23.232 6.44
Standard Dev. 9.69 4.16 41.28 4.71 0.13 94.86 6.36 1.26
Standard Error 1.94 0.83 8.26 0.94 0.03 18.97 1.27 0.25
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BODY COMPOSmON (% BODY FAT) FOR MEN*
Age
% ile 20-29 30-39 40-49 50-59 60+
99 52.4 S5.2 <6.6 <8.8 57.7
95 5.2 9.1 11.4 12.9 13.1 S
90 7.1 11.3 13.6 15.3 15.3
65 8.3 12.7 15.1 16.9 17.2
80 9.4 13.9 16.3 17.9 18.4 E
75 10.6 14.9 17.3 19.0 19.3
70 11.8 15.9 18.1 19.8 20.3
65 12.9 16.6 18.8 20.6 21.1
60 14.1 17.5 19.6 21.3 22.0 G
55 15.0 18.2 20.3 22.1 22.6
50 15.9 19.0 21.1 22.7 23.5
45 16.8 19.7 21.8 23.4 24.3
40 17.4 20.5 22.5 24.1 25.0 F
35 18.3 21.4 23.3 24.9 25.9
30 19.5 22.3 24.1 25.7 26.7
25 20.7 23.2 25.0 26.6 27.6
20 22.4 24.2 26.1 27.5 28.5 P
IS 23.9 25.5 27.3 28.8 29.7
10 25.9 27.3 28.9 30.3 31.2
5 29.1 29.9 31.5 32.4 33.4 VP
1 236.4 235.6 237.4 238.1 241.3
N = 1342 5611 5724 3275 984
TOTAL N = 16936
'Data provided by (he Instituie lor Aerobics Research, Dallas. TX (1994). S, superior E. excellent; G. 
good; F. lair: P. poor VP. very poor.
BODY COMPOSITION (% BODY FAT) FOR WOMEN*
Age
•/• ile 20-29 30-39 40-49 50-59 60+
99 55.4 57.3 <11.6 511.6 <15.4
95 10.8 13.4 16.1 18.8 16.8 S
90 14.5 15.5 18.5 21.6 21.1
85 16.0 16.9 20.3 23.6 23.5
80 17.1 18.0 21.3 25.0 25.1 E
75 18.2 19.1 22.4 25.8 26.7
70 19.0 20.0 23.5 26.6 27.5
65 19.8 20.8 24.3 27.4 28.5
60 20.6 21.6 24.9 28.5 29.3 G
55 21.3 22.4 25.5 29.2 29.9
50 22.1 23.1 26.4 30.1 30.9
45 22-7 24.0 27.3 30.8 31.8
40 23.7 24.9 28.1 31.6 32.5 F
35 24.4 26.0 29.0 32.6 33.0
30 25.4 27.0 30.1 33.5 34.3
25 26.6 28.1 31.1 34.3 35.5
20 27.7 29.3 32-1 35.6 36.6 P
15 29.8 31.0 33.3 36.6 38.0
10 32.1 32.8 35.0 37.9 39.3
5 35.4 35.7 37.8 39.6 40.5 VP
1 240.5 240.0 245.5 250.8 &47.0
N = 638 
TOTAL N = 4107
1336 1175 708 250
'Data provided by the Institute for Aerobics Research, Dallas. TX (1994). S. superior E. excellent- o. 
good; F. fair P. poor VP, very poor.
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BODY MASS INDEX
: 19 20 1 21 1 22 23
BODY M ittS INDEX 
24 j 25 I 26 1 27 28 29 ' 30 35 40 1
W elfltitdbs) 1
58 1 91 96 i 100 j 105 i 110 115 j 119 124 1 129 134 138 j 143 1 167 191
59 1 94 99 1 10^ I 109 114 119 124 128 1 133 138 143 ! 148 173 198
60 1 97 102 , 107 j 112 ! 11* 123 I 128 133 138 143 148 I 153 1 179 204
61 1 100 106 , 1 "  1 116 I 122 127 , 132 137 I 143 148 153 158 . 185 211
62 1 104 109 ' 115 ' 120 126 131 136 142 1 147 153 158 j 164 191 218
63 1 107 113 1 11* i 124 ! 130 135 1 141 146 152 158 163 I 169 1 197 225 j
64 j 110 116 122 128 134 140 145 151 1 157 163 169 174 204 232 I
65 114 120 1 126 1 132 i 138 144 150 156 162 168 174 1 180 1 210 240 I
66 j 118 124 130 136 142 148 155 161 167 173 179 186 216 247 1
67 121 127 ' 134 1 140 ! 146 153 I 159 166 , 172 178 185 1 191 1 223 z w  j
68 1 125 131 138 i} 144 1 158 164 171 ' 177 184 190 197 230 262
69 j 128 135 142 ' 149 155 162 ' 169 176 182 189 196 1 203 ! 236 270 1
70 132 139 1 ‘•^6 i 153 i 100 167 , 174 181 188 195 202 207 , 243 278 '
71 1 136 143 150 157 165 172 179 186 1 193 200 208 * 215 * 250 286 j
1 140 147 154 I 162 i 169 177 j 184 191 I 199 206 213 I M l  j 258 294
73 144 151 159 166 174 182 189 197 1 204 212 219
I
227 265 302 1
74 1 148 155 : 163 ' 171 ! 179 186 1 194 202 210 218 225 1 233 j 272 31, ,
75 152 160 168 1 176 184 192 200 208 ' 216 224 232 240 279 319 j
76 i 156 164 172 180 I 189 197 1 205 213 221 230 238 ; 246 > 287 328
Less than 20 20 -25 26 to 27 Higher than 27
Weight gain Acceptable range for most people but Escalating Dramatic risk of health problems
may be advisabie potential heaith probiems with weight gain Health risks
90
180 70
17060
160
30 60
15080
LU 140 LU90 W HR
lU0.6
LU
U .LL 1300.7100
50
0.8
1200.9110
110120
=1— 40
100130
90140
80150
3060
cmcm
Reprinted from: Bray GA and Gray DS: Obesity. Part 1 —Pathogenesis. Western Jestern
M ed 149:429-441. 1988.
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